{"count":22,"next":null,"previous":null,"results":[{"url":"https://lda.gov/api/v1/filings/43e16491-f4b2-4930-8b10-b19b065170c3/","filing_uuid":"43e16491-f4b2-4930-8b10-b19b065170c3","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/43e16491-f4b2-4930-8b10-b19b065170c3/print/","filing_document_content_type":"text/html","income":"20000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Matt McGinley","dt_posted":"2026-04-14T10:17:43-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"2503-D Harrison Street North #1210","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Arlington","registrant_state":"VA","registrant_zip":"22207","registrant":{"id":401103524,"url":"https://lda.gov/api/v1/registrants/401103524/","house_registrant_id":null,"name":"ADVANCED POLICY CONSULTING, LLC","description":"Consulting","address_1":"2503-D Harrison Street North #1210","address_2":null,"address_3":null,"address_4":null,"city":"Arlington","state":"VA","state_display":"Virginia","zip":"22207","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MATT MCGINLEY","contact_telephone":"+1 703-536-1705","dt_updated":"2026-07-24T11:29:57.639066-04:00"},"client":{"id":53847,"url":"https://lda.gov/api/v1/clients/53847/","client_id":53847,"name":"ATA ACTION","general_description":"Trade organization advocating for telehealth","client_government_entity":null,"client_self_select":false,"state":"VA","state_display":"Virginia","country":"US","country_display":"United States of America","ppb_state":"VA","ppb_state_display":"Virginia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2023-01-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Telehealth Expansion Act (H.R. 1650 / S. 763) Permanent Telehealth from Home Act (H.R. 1407) Audio-Only Telehealth Services Act (H.R. 1899) Expanded Provider Access Act (H.R. 1614) TREATS Act (H.R. 1627) PREVENT DIABETES Act (H.R. 1523) Sustainable Cardiopulmonary Rehabilitation in the Home Act (H.R. 783 / S. 248) Hospice Recertification Flexibility Act (H.R. 1720) Rural Telehealth and Education Enhancement Act (H.R. 290) Monitor Prescription Digital Therapeutics policy. H.R.6994 - To amend the Controlled Substances Act to modify requirements relating to the prescription of controlled substances by means of the Internet, and for other purposes.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":62356,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"MCGINLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":198,"name":"Natl Economic Council (NEC)"},{"id":19,"name":"Office of Natl Drug Control Policy (NDCP)"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"CONNECT for Health Act Reintroduction Telehealth Modernization Act Reintroduction Promote medicare Telehealth extension in government funding legislation.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":62356,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"MCGINLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":198,"name":"Natl Economic Council (NEC)"},{"id":19,"name":"Office of Natl Drug Control Policy (NDCP)"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/59530b7d-4f88-4151-962b-dde08b7f6a94/","filing_uuid":"59530b7d-4f88-4151-962b-dde08b7f6a94","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/59530b7d-4f88-4151-962b-dde08b7f6a94/print/","filing_document_content_type":"text/html","income":null,"expenses":"30000.00","expenses_method":"B","expenses_method_display":"B","posted_by_name":"Kyle Zebley","dt_posted":"2026-04-17T10:08:49-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"601 13th St NW","registrant_address_2":"12th Floor","registrant_different_address":true,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":401106410,"url":"https://lda.gov/api/v1/registrants/401106410/","house_registrant_id":45477,"name":"ATA ACTION","description":null,"address_1":"601 13th St NW","address_2":"12th Floor","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"KYLE ZEBLEY","contact_telephone":"+1 412-760-8098","dt_updated":"2026-08-31T11:40:33.575220-04:00"},"client":{"id":50919,"url":"https://lda.gov/api/v1/clients/50919/","client_id":50919,"name":"ATA ACTION","general_description":"Trade organization advocating for telehealth","client_government_entity":null,"client_self_select":true,"state":"VA","state_display":"Virginia","country":"US","country_display":"United States of America","ppb_state":"VA","ppb_state_display":"Virginia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2022-01-01"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"CONNECT for Health Act Reintroduction ATA Action strongly supports the Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act, the most comprehensive bipartisan telehealth legislation in Congress. The bill would permanently remove geographic and originating site restrictions, expand eligible providers, and allow patients to access care from their homes. It represents a critical step toward ensuring telehealth remains a foundational element of modern healthcare. Telehealth Modernization Act Reintroduction ATA Action endorses the Telehealth Modernization Act, which codifies the key Medicare telehealth flexibilities first introduced during the COVID-19 pandemic. The bill eliminates outdated site restrictions and empowers patients to receive care where and when they need it. This legislation is essential to maintaining progress and providing certainty to patients, providers, and health systems.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":139283,"prefix":"mr","prefix_display":"MR.","first_name":"KYLE","nickname":null,"middle_name":null,"last_name":"ZEBLEY","suffix":null,"suffix_display":null},"covered_position":"Legislative Director/Senior Legislative Assistant/Legislative Assistant, Rep. Tom Price (R-GA); Chief of Staff/Senior Advisor, HHS Office of the Secretary","new":false},{"lobbyist":{"id":138681,"prefix":null,"prefix_display":null,"first_name":"ALEXIS","nickname":null,"middle_name":"MARIA","last_name":"APPLE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"ATA Action - Federal Legislative Priorities (119th Congress) As of Q4 2025, ATA Action continues to support and lobby for a broad portfolio of bipartisan legislation aimed at making telehealth and digital health a permanent, integrated part of care delivery in the U.S. healthcare system. Below is a summary of the legislation we are actively engaging on: 🔹 Top Legislative Priorities Telehealth Expansion Act (H.R. 1650 / S. 763) Sponsors: Rep. Arrington (R-TX), Rep. Susie Lee (D-NV), Sen. Daines (R-MT), Sen. Cortez Masto (D-NV) → Makes permanent the ability to offer pre-deductible telehealth services under high-deductible health plans linked to HSAs. Permanent Telehealth from Home Act (H.R. 1407) Sponsors: Rep. Buchanan (R-FL), Rep. Max Miller (R-OH), Rep. Mike Thompson (D-CA) → Eliminates originating site and geographic restrictions for Medicare telehealth services permanently. Audio-Only Telehealth Services Act (H.R. 1899) Sponsors: Rep. Feenstra (R-IA), Rep. Pappas (D-NH) → Makes permanent coverage of audio-only services in Medicare. Expanded Provider Access Act (H.R. 1614) Sponsors: Rep. Kelly (R-PA), Rep. Mike Thompson (D-CA) → Permits therapists, audiologists, and speech-language pathologists to deliver telehealth services permanently. TREATS Act (H.R. 1627) Sponsors: Rep. Norcross (D-NJ), Rep. Fitzpatrick (R-PA) → Permanently waives the in-person requirement for prescribing controlled substances (Schedules III-IV) via telehealth for substance use and opioid use disorders. 🔹 Additional Supported Legislation PREVENT DIABETES Act (H.R. 1523) Sponsors: Rep. DeGette (D-CO), Rep. Bilirakis (R-FL) → Expands Medicare Diabetes Prevention Program to include virtual suppliers. Sustainable Cardiopulmonary Rehabilitation in the Home Act (H.R. 783 / S. 248) Sponsors: Rep. Joyce (R-PA), Rep. Peters (D-CA), Sen. Blackburn (R-TN), Sen. Klobuchar (D-MN) → Makes permanent the option to provide cardiopulmonary rehab services at home via telehealth. Hospice Recertification Flexibility Act (H.R. 1720) Sponsors: Rep. Carol Miller (R-WV), Rep. Jared Golden (D-ME) → Allows hospice recertification visits via telehealth beyond 180 days. Rural Telehealth and Education Enhancement Act (H.R. 290) Sponsors: Rep. Langworthy (R-NY), Rep. Pingree (D-ME) → Reauthorizes USDAs Distance Learning and Telemedicine grant program through FY2030. ATA Action is actively advocating for these bills through direct engagement with congressional offices, testimony, coalition coordination, and public policy campaigns. This legislative portfolio reflects our commitment to securing permanent access to telehealth and integrating next-generation digital tools across care settings nationwide.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":139283,"prefix":"mr","prefix_display":"MR.","first_name":"KYLE","nickname":null,"middle_name":null,"last_name":"ZEBLEY","suffix":null,"suffix_display":null},"covered_position":"Legislative Director/Senior Legislative Assistant/Legislative Assistant, Rep. Tom Price (R-GA); Chief of Staff/Senior Advisor, HHS Office of the Secretary","new":false},{"lobbyist":{"id":138681,"prefix":null,"prefix_display":null,"first_name":"ALEXIS","nickname":null,"middle_name":"MARIA","last_name":"APPLE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/a6e62edd-dc28-4d2f-8d0d-a44c10015a10/","filing_uuid":"a6e62edd-dc28-4d2f-8d0d-a44c10015a10","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/a6e62edd-dc28-4d2f-8d0d-a44c10015a10/print/","filing_document_content_type":"text/html","income":null,"expenses":"160000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Laura Katherine Bender","dt_posted":"2026-04-20T13:16:42-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"1331 Pennsylvania Ave NW","registrant_address_2":"Suite 1425 North","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":2811,"url":"https://lda.gov/api/v1/registrants/2811/","house_registrant_id":30549,"name":"AMERICAN LUNG ASSOCIATION","description":null,"address_1":"1331 Pennsylvania Ave NW","address_2":"Suite 1425 North","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"LAURA BENDER","contact_telephone":"+1 202-715-3457","dt_updated":"2026-07-20T09:13:00.293676-04:00"},"client":{"id":103597,"url":"https://lda.gov/api/v1/clients/103597/","client_id":12,"name":"AMERICAN LUNG ASSOCIATION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-02"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Issues related to lung disease treatment, prevention and research; public health; tobacco control and air pollution; Issues related to the Affordable Care Act; Issues related to COVID-19 Response; Issues related to infrastructure; Issues related to agency restructuring; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S 317 Charitable Act; HR 801 Charitable Act; Consolidated Appropriations Act, 2026; Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026; Breaking the Gridlock Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150198,"prefix":"mrs","prefix_display":"MRS.","first_name":"ELIZABETH","nickname":null,"middle_name":"ANNE MUELLER","last_name":"SCOTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":49,"name":"Environmental Protection Agency (EPA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CAW","general_issue_code_display":"Clean Air and Water (quality)","description":"Issues related to the health impacts of air pollution and climate change; Issues related to air pollution from stationary and mobile sources; Issues related to the Clean Air Act; Issues related to California Clean Air Act waivers; Issues related to permitting and regulatory reforms; Issues related to infrastructure; Issues related to agency restructuring; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; Issues related to implementation of the Inflation Reduction Act; Issues related to appliance efficiency; issues related to prescribed burning;; S1072 Stop California from Advancing Regulatory Burden Act; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; HR 313 Natural Gas Tax Repeal Act; S 143 Natural Gas Tax Repeal Act; HR 471 Fix Our Forests; HJ Res 15/SJ Res 4 Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Energy relating to \"Energy Conservation Program: Energy Conservation Standards for Commercial Water Heating Equipment\"; HR 903/S 341 Smoke and Heat Ready Communities Act; S 541 Eliminating Lavish Incentives to Electric Vehicles Act; HR 1449 Energy Resilient Communities Act;; S 711 Transportation Freedom Act; HR 1651 To nullify the final rule issued by the Environmental Protection Agency relating to \"New Source Performance Standards for Greenhouse Gas Emissions From New, Modified, and Reconstructed Fossil Fuel-Fired Electric Generating Units; Emission Guidelines for Greenhouse Gas Emissions From Existing Fossil Fuel-Fired Electric Generating Units; and Repeal of the Affordable Clean Energy Rule\"; HR 1415/S 623 No Industrial Restrictions In Secret (No IRIS) Act; HR 2140 DERA Act 2025; S 1072 A bill to amend the Clean Air Act to eliminate a waiver under that Act, to eliminate an authorization for States to use new motor vehicle emission and new motor vehicle engine emissions standards identical to standards adopted in California, and for other purposes; HR 2165 Choice in Automobile Retail Sales (CARS) Act; HR 346 Preserving Choice in Vehicle Purchases Act; S 990 Freedom to Haul Act; HR 2288 To nullify the final rule of the Environmental Protection Agency titled \"Reconsideration of the National Ambient Air Quality Standards for Particulate Matter\"; ; HJ Res 30/SJ Res 14 Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"Phasedown of Hydrofluorocarbons: Management of Certain Hydrofluorocarbons and Substitutes Under the American Innovation and Manufacturing Act of 2020\"; S 1166 Excess Urban Heat Mitigation Act; HR 4214 To require the Administrator of the Environmental Protection Agency to publish, concurrently with any final rule establishing or revising a national ambient air quality standard, regulations and guidance for implementing the standard, including information relating to submission and consideration of a preconstruction permit application under the new or revised standard, and for other purposes; HR 3889/S 2015 National Prescribed Fire Act; H.Res. 585 Recognizing the threat of extreme weather to childrens health and wellbeing, and expressing the sense of Congress that solutions must be rapidly and equitably developed and deployed to address the unique vulnerabilities and needs of children; HR 4443/S 2298 Asuncion Valdivia Heat Illness, Injury, and Fatality Prevention Act; S 2340/HR 4515 Climate Change Health Protection and Promotion Act of 2025; HR 4744/S 2445 Community Mental Wellness and Resilience Act; HR 161 New Source Review Permitting Improvement Act; HR HR 6387 Fire Improvement and Reforming Exceptional Events Act; HR 6409 Foreign Emissions and Nonattainment Clarification for Economic Stability Act; HR 6398 Reducing and Eliminating Duplicative Environmental Regulations Act; HR 6373 Air Permitting Improvements to Protect National Security Act; H.R. 4214 Clean Air and Building Infrastructure Improvement Act; S 2431 Department of the Interior, Environment, and Related Agencies Appropriations Act, 2026; HR 4754 Department of the Interior, Environment, and Related Agencies Appropriations Act, 2026; HR 4553 Energy and Water Development and Related Agencies Appropriations Act, 2026; HR 4776 SPEED Act; S 3529 Public Health Air Quality Act; S 3007, Diesel Truck Liberation Act; S 237 Honoring Our Fallen Heroes Act; Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026; Protection of Lawful Commerce in Stone Slab Products Act; Home Appliance Protection and Affordability Act; Homeowner Energy Freedom Act; Energy Bills Relief Act; Promoting Reduction of Emissions through Landscaping Act; Discussion Draft of Legislation to Modernize the Toxic Substances Control Act; SHOWER Act; Affordable HOMES Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":150198,"prefix":"mrs","prefix_display":"MRS.","first_name":"ELIZABETH","nickname":null,"middle_name":"ANNE MUELLER","last_name":"SCOTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":33,"name":"Energy, Dept of"},{"id":49,"name":"Environmental Protection Agency (EPA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":36,"name":"Interior, Dept of (DOI)"},{"id":188,"name":"Internal Revenue Service (IRS)"},{"id":175,"name":"Natl Highway Traffic Safety Administration (NHTSA)"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"},{"id":40,"name":"Transportation, Dept of (DOT)"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to lung disease treatment, prevention and research; Issues related to public health; Issues related asthma, COPD, influenza, lung cancer, pneumonia, pulmonary fibrosis, tuberculosis and other lung diseases; Issues related to tobacco cessation; Issues related to the Affordable Care Act; Issues related to agency restructuring; Issues related to the Childrens Health Insurance Program; Issues related to Medicaid; Issues related to ERISA; Issues related to COVID-19 Response; Issues related to vaccines; Issues related to infrastructure; Issues related to supplemental oxygen; Issues related to the implementation of the No Surprises Act; Issues related to Medicare sequestration; Issues related to Cancer Moonshot; Issues related to short-term limited duration plans; Issues related to Healthy Future Taskforce; Issues related to regulatory reform; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 717Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; H.R. 3701 Family Vaccine Protection Act; H.R. 3521 Clinical Trial Modernization Act; HR 4417 Mobile Cancer Screening Act HR 3701 Family Vaccine Protection Act; HR 5304Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; S 2587 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; HR 5278/S 2756 Affordable Inhalers and Nebulizers Act of 2025; HR 6703 Lower Health Care Premiums for All Americans Act; S 2466 Senior Savings Protection Act; HR Senior Savings Protection Act; HR 6052 Elijah E. Cummings Family Asthma Act; HR 6319 Benay Taub Lung Cancer Research Act; HR 45448 Protecting Free Vaccines Act; Consolidated Appropriations Act, 2026; Breaking the Gridlock Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Issues relating to FY25 appropriations; Issues relating to the Presidents FY26 budget; Issues related to asthma, COPD, influenza, lung cancer, pneumonia, pulmonary fibrosis, tuberculosis and other lung diseases; Issues related to NIH reorganization; Issues related to agency restructuring; Issues related to lung disease treatment, prevention and research; Issues related to COVID-19; Issues related to telehealth; Issues related to infrastructure; Issues related to supplemental oxygen; Issues related to health equity; Issues related to Cancer Moonshot; Issues related to CDC public health workforce and data modernization; Issues related to regulatory reform; Issues related to Medicaid; H.R. 1509/S. 752, the Accelerating Kids Access to Care Act; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 717 Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; H.R. 3521 Clinical Trial Modernization Act; HR 4417 Mobile Cancer Screening Act; HR 5304 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; S 2587 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; HR 5278/S 2756 Affordable Inhalers and Nebulizers Act of 2025; HR 45448 Protecting Free Vaccines Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to lung disease treatment, prevention and research; Issues related to public health; Issues related to tobacco cessation; Issues related to health inequities; Issues related to Medicaid waivers; Issues related to agency restructuring; Issues related to the Affordable Care Act; Issues related to supplemental oxygen; Issues related to access to healthcare; Issues related to COVID-19 Response; Issues related to Medicaid; Issues related to infrastructure; Issues related to health equity; Issues related to the implementation of the No Surprises Act; Issues related to Medicaid; Issues relating to the Presidents FY25 budget; Issues related to regulatory reform; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; S 717 Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; HR 6178 Increasing Access to Lung Cancer Screening Act; HR 6321 Lung Cancer Medicare Access to Precise Testing Act; HR 6320 Improving Medicaid Precision and Cancer Test Act of 2025","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"Issues related to tobacco use, lung cancer, lung disease treatment, prevention and research; and public health; Issues relating to the Presidents FY25 budget; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; Issues related to the Congressional Directed Medical Research Program; HR 4016 Department of Defense Appropriations Act, 2026; S 2572 Department of Defense Appropriations Act, 2026","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TOB","general_issue_code_display":"Tobacco","description":"Issues related to lung disease treatment, prevention and research; Issues related to tobacco cessation; Issues related to agency restructuring; Issues related to smokefree air; Issues related to the Tobacco Control Act; Issues related to tobacco smuggling; Issues related to the Affordable Care Act; Issues related to menthol cigarettes; Issues related to tobacco prevention; Issues related to youth cessation research; Issues related to nicotine; Issues related to health equity; Issues related to COVID-19 Response; Issues related to tobacco litter; Issues related to synthetic nicotine; Issues related to regulatory reform; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; S. 2171 A bill to amend title 38, united States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes; H.R. 4121 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026; S 2256 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026; HR 6844 The Tobacco Tracking, Reporting, and Accountability for Compliance in Enforcement Act; HR 6845 Strengthening Task Force Operations to Prevent Illicit Vaping Act; S 3569 Strengthening Task Force Operations to Prevent Illicit Vaping Act; Resources to Prevent Youth Vaping Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Issues related to taxes on tobacco products; Issues related to the Affordable Care Act; Issues related to COVID-19; Issues related to infrastructure; Issues relating to the Presidents FY25 budget; Issues relating to FY26 appropriations; S 317 Charitable Act; HR 801 Charitable Act; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":150198,"prefix":"mrs","prefix_display":"MRS.","first_name":"ELIZABETH","nickname":null,"middle_name":"ANNE MUELLER","last_name":"SCOTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"Issues related to lung disease treatment, prevention and research; Issues related to burn pits; Issues related to tobacco cessation; Issues related to smokefree air; Issues related to COVID-19 Response; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S. 2171 A bill to amend title 38, united States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/a6e62edd-dc28-4d2f-8d0d-a44c10015a10/","filing_uuid":"a6e62edd-dc28-4d2f-8d0d-a44c10015a10","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/a6e62edd-dc28-4d2f-8d0d-a44c10015a10/print/","filing_document_content_type":"text/html","income":null,"expenses":"160000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Laura Katherine Bender","dt_posted":"2026-04-20T13:16:42-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"1331 Pennsylvania Ave NW","registrant_address_2":"Suite 1425 North","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":2811,"url":"https://lda.gov/api/v1/registrants/2811/","house_registrant_id":30549,"name":"AMERICAN LUNG ASSOCIATION","description":null,"address_1":"1331 Pennsylvania Ave NW","address_2":"Suite 1425 North","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"LAURA BENDER","contact_telephone":"+1 202-715-3457","dt_updated":"2026-07-20T09:13:00.293676-04:00"},"client":{"id":103597,"url":"https://lda.gov/api/v1/clients/103597/","client_id":12,"name":"AMERICAN LUNG ASSOCIATION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-02"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Issues related to lung disease treatment, prevention and research; public health; tobacco control and air pollution; Issues related to the Affordable Care Act; Issues related to COVID-19 Response; Issues related to infrastructure; Issues related to agency restructuring; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S 317 Charitable Act; HR 801 Charitable Act; Consolidated Appropriations Act, 2026; Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026; Breaking the Gridlock Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150198,"prefix":"mrs","prefix_display":"MRS.","first_name":"ELIZABETH","nickname":null,"middle_name":"ANNE MUELLER","last_name":"SCOTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":49,"name":"Environmental Protection Agency (EPA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CAW","general_issue_code_display":"Clean Air and Water (quality)","description":"Issues related to the health impacts of air pollution and climate change; Issues related to air pollution from stationary and mobile sources; Issues related to the Clean Air Act; Issues related to California Clean Air Act waivers; Issues related to permitting and regulatory reforms; Issues related to infrastructure; Issues related to agency restructuring; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; Issues related to implementation of the Inflation Reduction Act; Issues related to appliance efficiency; issues related to prescribed burning;; S1072 Stop California from Advancing Regulatory Burden Act; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; HR 313 Natural Gas Tax Repeal Act; S 143 Natural Gas Tax Repeal Act; HR 471 Fix Our Forests; HJ Res 15/SJ Res 4 Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Energy relating to \"Energy Conservation Program: Energy Conservation Standards for Commercial Water Heating Equipment\"; HR 903/S 341 Smoke and Heat Ready Communities Act; S 541 Eliminating Lavish Incentives to Electric Vehicles Act; HR 1449 Energy Resilient Communities Act;; S 711 Transportation Freedom Act; HR 1651 To nullify the final rule issued by the Environmental Protection Agency relating to \"New Source Performance Standards for Greenhouse Gas Emissions From New, Modified, and Reconstructed Fossil Fuel-Fired Electric Generating Units; Emission Guidelines for Greenhouse Gas Emissions From Existing Fossil Fuel-Fired Electric Generating Units; and Repeal of the Affordable Clean Energy Rule\"; HR 1415/S 623 No Industrial Restrictions In Secret (No IRIS) Act; HR 2140 DERA Act 2025; S 1072 A bill to amend the Clean Air Act to eliminate a waiver under that Act, to eliminate an authorization for States to use new motor vehicle emission and new motor vehicle engine emissions standards identical to standards adopted in California, and for other purposes; HR 2165 Choice in Automobile Retail Sales (CARS) Act; HR 346 Preserving Choice in Vehicle Purchases Act; S 990 Freedom to Haul Act; HR 2288 To nullify the final rule of the Environmental Protection Agency titled \"Reconsideration of the National Ambient Air Quality Standards for Particulate Matter\"; ; HJ Res 30/SJ Res 14 Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"Phasedown of Hydrofluorocarbons: Management of Certain Hydrofluorocarbons and Substitutes Under the American Innovation and Manufacturing Act of 2020\"; S 1166 Excess Urban Heat Mitigation Act; HR 4214 To require the Administrator of the Environmental Protection Agency to publish, concurrently with any final rule establishing or revising a national ambient air quality standard, regulations and guidance for implementing the standard, including information relating to submission and consideration of a preconstruction permit application under the new or revised standard, and for other purposes; HR 3889/S 2015 National Prescribed Fire Act; H.Res. 585 Recognizing the threat of extreme weather to childrens health and wellbeing, and expressing the sense of Congress that solutions must be rapidly and equitably developed and deployed to address the unique vulnerabilities and needs of children; HR 4443/S 2298 Asuncion Valdivia Heat Illness, Injury, and Fatality Prevention Act; S 2340/HR 4515 Climate Change Health Protection and Promotion Act of 2025; HR 4744/S 2445 Community Mental Wellness and Resilience Act; HR 161 New Source Review Permitting Improvement Act; HR HR 6387 Fire Improvement and Reforming Exceptional Events Act; HR 6409 Foreign Emissions and Nonattainment Clarification for Economic Stability Act; HR 6398 Reducing and Eliminating Duplicative Environmental Regulations Act; HR 6373 Air Permitting Improvements to Protect National Security Act; H.R. 4214 Clean Air and Building Infrastructure Improvement Act; S 2431 Department of the Interior, Environment, and Related Agencies Appropriations Act, 2026; HR 4754 Department of the Interior, Environment, and Related Agencies Appropriations Act, 2026; HR 4553 Energy and Water Development and Related Agencies Appropriations Act, 2026; HR 4776 SPEED Act; S 3529 Public Health Air Quality Act; S 3007, Diesel Truck Liberation Act; S 237 Honoring Our Fallen Heroes Act; Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026; Protection of Lawful Commerce in Stone Slab Products Act; Home Appliance Protection and Affordability Act; Homeowner Energy Freedom Act; Energy Bills Relief Act; Promoting Reduction of Emissions through Landscaping Act; Discussion Draft of Legislation to Modernize the Toxic Substances Control Act; SHOWER Act; Affordable HOMES Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":150198,"prefix":"mrs","prefix_display":"MRS.","first_name":"ELIZABETH","nickname":null,"middle_name":"ANNE MUELLER","last_name":"SCOTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":33,"name":"Energy, Dept of"},{"id":49,"name":"Environmental Protection Agency (EPA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":36,"name":"Interior, Dept of (DOI)"},{"id":188,"name":"Internal Revenue Service (IRS)"},{"id":175,"name":"Natl Highway Traffic Safety Administration (NHTSA)"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"},{"id":40,"name":"Transportation, Dept of (DOT)"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to lung disease treatment, prevention and research; Issues related to public health; Issues related asthma, COPD, influenza, lung cancer, pneumonia, pulmonary fibrosis, tuberculosis and other lung diseases; Issues related to tobacco cessation; Issues related to the Affordable Care Act; Issues related to agency restructuring; Issues related to the Childrens Health Insurance Program; Issues related to Medicaid; Issues related to ERISA; Issues related to COVID-19 Response; Issues related to vaccines; Issues related to infrastructure; Issues related to supplemental oxygen; Issues related to the implementation of the No Surprises Act; Issues related to Medicare sequestration; Issues related to Cancer Moonshot; Issues related to short-term limited duration plans; Issues related to Healthy Future Taskforce; Issues related to regulatory reform; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 717Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; H.R. 3701 Family Vaccine Protection Act; H.R. 3521 Clinical Trial Modernization Act; HR 4417 Mobile Cancer Screening Act HR 3701 Family Vaccine Protection Act; HR 5304Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; S 2587 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; HR 5278/S 2756 Affordable Inhalers and Nebulizers Act of 2025; HR 6703 Lower Health Care Premiums for All Americans Act; S 2466 Senior Savings Protection Act; HR Senior Savings Protection Act; HR 6052 Elijah E. Cummings Family Asthma Act; HR 6319 Benay Taub Lung Cancer Research Act; HR 45448 Protecting Free Vaccines Act; Consolidated Appropriations Act, 2026; Breaking the Gridlock Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Issues relating to FY25 appropriations; Issues relating to the Presidents FY26 budget; Issues related to asthma, COPD, influenza, lung cancer, pneumonia, pulmonary fibrosis, tuberculosis and other lung diseases; Issues related to NIH reorganization; Issues related to agency restructuring; Issues related to lung disease treatment, prevention and research; Issues related to COVID-19; Issues related to telehealth; Issues related to infrastructure; Issues related to supplemental oxygen; Issues related to health equity; Issues related to Cancer Moonshot; Issues related to CDC public health workforce and data modernization; Issues related to regulatory reform; Issues related to Medicaid; H.R. 1509/S. 752, the Accelerating Kids Access to Care Act; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 717 Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; H.R. 3521 Clinical Trial Modernization Act; HR 4417 Mobile Cancer Screening Act; HR 5304 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; S 2587 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; HR 5278/S 2756 Affordable Inhalers and Nebulizers Act of 2025; HR 45448 Protecting Free Vaccines Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to lung disease treatment, prevention and research; Issues related to public health; Issues related to tobacco cessation; Issues related to health inequities; Issues related to Medicaid waivers; Issues related to agency restructuring; Issues related to the Affordable Care Act; Issues related to supplemental oxygen; Issues related to access to healthcare; Issues related to COVID-19 Response; Issues related to Medicaid; Issues related to infrastructure; Issues related to health equity; Issues related to the implementation of the No Surprises Act; Issues related to Medicaid; Issues relating to the Presidents FY25 budget; Issues related to regulatory reform; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; S 717 Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; HR 6178 Increasing Access to Lung Cancer Screening Act; HR 6321 Lung Cancer Medicare Access to Precise Testing Act; HR 6320 Improving Medicaid Precision and Cancer Test Act of 2025","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"Issues related to tobacco use, lung cancer, lung disease treatment, prevention and research; and public health; Issues relating to the Presidents FY25 budget; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; Issues related to the Congressional Directed Medical Research Program; HR 4016 Department of Defense Appropriations Act, 2026; S 2572 Department of Defense Appropriations Act, 2026","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TOB","general_issue_code_display":"Tobacco","description":"Issues related to lung disease treatment, prevention and research; Issues related to tobacco cessation; Issues related to agency restructuring; Issues related to smokefree air; Issues related to the Tobacco Control Act; Issues related to tobacco smuggling; Issues related to the Affordable Care Act; Issues related to menthol cigarettes; Issues related to tobacco prevention; Issues related to youth cessation research; Issues related to nicotine; Issues related to health equity; Issues related to COVID-19 Response; Issues related to tobacco litter; Issues related to synthetic nicotine; Issues related to regulatory reform; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; S. 2171 A bill to amend title 38, united States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes; H.R. 4121 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026; S 2256 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026; HR 6844 The Tobacco Tracking, Reporting, and Accountability for Compliance in Enforcement Act; HR 6845 Strengthening Task Force Operations to Prevent Illicit Vaping Act; S 3569 Strengthening Task Force Operations to Prevent Illicit Vaping Act; Resources to Prevent Youth Vaping Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Issues related to taxes on tobacco products; Issues related to the Affordable Care Act; Issues related to COVID-19; Issues related to infrastructure; Issues relating to the Presidents FY25 budget; Issues relating to FY26 appropriations; S 317 Charitable Act; HR 801 Charitable Act; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":150198,"prefix":"mrs","prefix_display":"MRS.","first_name":"ELIZABETH","nickname":null,"middle_name":"ANNE MUELLER","last_name":"SCOTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"Issues related to lung disease treatment, prevention and research; Issues related to burn pits; Issues related to tobacco cessation; Issues related to smokefree air; Issues related to COVID-19 Response; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S. 2171 A bill to amend title 38, united States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/a6e62edd-dc28-4d2f-8d0d-a44c10015a10/","filing_uuid":"a6e62edd-dc28-4d2f-8d0d-a44c10015a10","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/a6e62edd-dc28-4d2f-8d0d-a44c10015a10/print/","filing_document_content_type":"text/html","income":null,"expenses":"160000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Laura Katherine Bender","dt_posted":"2026-04-20T13:16:42-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"1331 Pennsylvania Ave NW","registrant_address_2":"Suite 1425 North","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":2811,"url":"https://lda.gov/api/v1/registrants/2811/","house_registrant_id":30549,"name":"AMERICAN LUNG ASSOCIATION","description":null,"address_1":"1331 Pennsylvania Ave NW","address_2":"Suite 1425 North","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"LAURA BENDER","contact_telephone":"+1 202-715-3457","dt_updated":"2026-07-20T09:13:00.293676-04:00"},"client":{"id":103597,"url":"https://lda.gov/api/v1/clients/103597/","client_id":12,"name":"AMERICAN LUNG ASSOCIATION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-02"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Issues related to lung disease treatment, prevention and research; public health; tobacco control and air pollution; Issues related to the Affordable Care Act; Issues related to COVID-19 Response; Issues related to infrastructure; Issues related to agency restructuring; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S 317 Charitable Act; HR 801 Charitable Act; Consolidated Appropriations Act, 2026; Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026; Breaking the Gridlock Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150198,"prefix":"mrs","prefix_display":"MRS.","first_name":"ELIZABETH","nickname":null,"middle_name":"ANNE MUELLER","last_name":"SCOTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":49,"name":"Environmental Protection Agency (EPA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CAW","general_issue_code_display":"Clean Air and Water (quality)","description":"Issues related to the health impacts of air pollution and climate change; Issues related to air pollution from stationary and mobile sources; Issues related to the Clean Air Act; Issues related to California Clean Air Act waivers; Issues related to permitting and regulatory reforms; Issues related to infrastructure; Issues related to agency restructuring; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; Issues related to implementation of the Inflation Reduction Act; Issues related to appliance efficiency; issues related to prescribed burning;; S1072 Stop California from Advancing Regulatory Burden Act; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; HR 313 Natural Gas Tax Repeal Act; S 143 Natural Gas Tax Repeal Act; HR 471 Fix Our Forests; HJ Res 15/SJ Res 4 Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Energy relating to \"Energy Conservation Program: Energy Conservation Standards for Commercial Water Heating Equipment\"; HR 903/S 341 Smoke and Heat Ready Communities Act; S 541 Eliminating Lavish Incentives to Electric Vehicles Act; HR 1449 Energy Resilient Communities Act;; S 711 Transportation Freedom Act; HR 1651 To nullify the final rule issued by the Environmental Protection Agency relating to \"New Source Performance Standards for Greenhouse Gas Emissions From New, Modified, and Reconstructed Fossil Fuel-Fired Electric Generating Units; Emission Guidelines for Greenhouse Gas Emissions From Existing Fossil Fuel-Fired Electric Generating Units; and Repeal of the Affordable Clean Energy Rule\"; HR 1415/S 623 No Industrial Restrictions In Secret (No IRIS) Act; HR 2140 DERA Act 2025; S 1072 A bill to amend the Clean Air Act to eliminate a waiver under that Act, to eliminate an authorization for States to use new motor vehicle emission and new motor vehicle engine emissions standards identical to standards adopted in California, and for other purposes; HR 2165 Choice in Automobile Retail Sales (CARS) Act; HR 346 Preserving Choice in Vehicle Purchases Act; S 990 Freedom to Haul Act; HR 2288 To nullify the final rule of the Environmental Protection Agency titled \"Reconsideration of the National Ambient Air Quality Standards for Particulate Matter\"; ; HJ Res 30/SJ Res 14 Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"Phasedown of Hydrofluorocarbons: Management of Certain Hydrofluorocarbons and Substitutes Under the American Innovation and Manufacturing Act of 2020\"; S 1166 Excess Urban Heat Mitigation Act; HR 4214 To require the Administrator of the Environmental Protection Agency to publish, concurrently with any final rule establishing or revising a national ambient air quality standard, regulations and guidance for implementing the standard, including information relating to submission and consideration of a preconstruction permit application under the new or revised standard, and for other purposes; HR 3889/S 2015 National Prescribed Fire Act; H.Res. 585 Recognizing the threat of extreme weather to childrens health and wellbeing, and expressing the sense of Congress that solutions must be rapidly and equitably developed and deployed to address the unique vulnerabilities and needs of children; HR 4443/S 2298 Asuncion Valdivia Heat Illness, Injury, and Fatality Prevention Act; S 2340/HR 4515 Climate Change Health Protection and Promotion Act of 2025; HR 4744/S 2445 Community Mental Wellness and Resilience Act; HR 161 New Source Review Permitting Improvement Act; HR HR 6387 Fire Improvement and Reforming Exceptional Events Act; HR 6409 Foreign Emissions and Nonattainment Clarification for Economic Stability Act; HR 6398 Reducing and Eliminating Duplicative Environmental Regulations Act; HR 6373 Air Permitting Improvements to Protect National Security Act; H.R. 4214 Clean Air and Building Infrastructure Improvement Act; S 2431 Department of the Interior, Environment, and Related Agencies Appropriations Act, 2026; HR 4754 Department of the Interior, Environment, and Related Agencies Appropriations Act, 2026; HR 4553 Energy and Water Development and Related Agencies Appropriations Act, 2026; HR 4776 SPEED Act; S 3529 Public Health Air Quality Act; S 3007, Diesel Truck Liberation Act; S 237 Honoring Our Fallen Heroes Act; Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026; Protection of Lawful Commerce in Stone Slab Products Act; Home Appliance Protection and Affordability Act; Homeowner Energy Freedom Act; Energy Bills Relief Act; Promoting Reduction of Emissions through Landscaping Act; Discussion Draft of Legislation to Modernize the Toxic Substances Control Act; SHOWER Act; Affordable HOMES Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":150198,"prefix":"mrs","prefix_display":"MRS.","first_name":"ELIZABETH","nickname":null,"middle_name":"ANNE MUELLER","last_name":"SCOTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":33,"name":"Energy, Dept of"},{"id":49,"name":"Environmental Protection Agency (EPA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":36,"name":"Interior, Dept of (DOI)"},{"id":188,"name":"Internal Revenue Service (IRS)"},{"id":175,"name":"Natl Highway Traffic Safety Administration (NHTSA)"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"},{"id":40,"name":"Transportation, Dept of (DOT)"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to lung disease treatment, prevention and research; Issues related to public health; Issues related asthma, COPD, influenza, lung cancer, pneumonia, pulmonary fibrosis, tuberculosis and other lung diseases; Issues related to tobacco cessation; Issues related to the Affordable Care Act; Issues related to agency restructuring; Issues related to the Childrens Health Insurance Program; Issues related to Medicaid; Issues related to ERISA; Issues related to COVID-19 Response; Issues related to vaccines; Issues related to infrastructure; Issues related to supplemental oxygen; Issues related to the implementation of the No Surprises Act; Issues related to Medicare sequestration; Issues related to Cancer Moonshot; Issues related to short-term limited duration plans; Issues related to Healthy Future Taskforce; Issues related to regulatory reform; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 717Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; H.R. 3701 Family Vaccine Protection Act; H.R. 3521 Clinical Trial Modernization Act; HR 4417 Mobile Cancer Screening Act HR 3701 Family Vaccine Protection Act; HR 5304Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; S 2587 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; HR 5278/S 2756 Affordable Inhalers and Nebulizers Act of 2025; HR 6703 Lower Health Care Premiums for All Americans Act; S 2466 Senior Savings Protection Act; HR Senior Savings Protection Act; HR 6052 Elijah E. Cummings Family Asthma Act; HR 6319 Benay Taub Lung Cancer Research Act; HR 45448 Protecting Free Vaccines Act; Consolidated Appropriations Act, 2026; Breaking the Gridlock Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Issues relating to FY25 appropriations; Issues relating to the Presidents FY26 budget; Issues related to asthma, COPD, influenza, lung cancer, pneumonia, pulmonary fibrosis, tuberculosis and other lung diseases; Issues related to NIH reorganization; Issues related to agency restructuring; Issues related to lung disease treatment, prevention and research; Issues related to COVID-19; Issues related to telehealth; Issues related to infrastructure; Issues related to supplemental oxygen; Issues related to health equity; Issues related to Cancer Moonshot; Issues related to CDC public health workforce and data modernization; Issues related to regulatory reform; Issues related to Medicaid; H.R. 1509/S. 752, the Accelerating Kids Access to Care Act; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 717 Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; H.R. 3521 Clinical Trial Modernization Act; HR 4417 Mobile Cancer Screening Act; HR 5304 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; S 2587 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; HR 5278/S 2756 Affordable Inhalers and Nebulizers Act of 2025; HR 45448 Protecting Free Vaccines Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to lung disease treatment, prevention and research; Issues related to public health; Issues related to tobacco cessation; Issues related to health inequities; Issues related to Medicaid waivers; Issues related to agency restructuring; Issues related to the Affordable Care Act; Issues related to supplemental oxygen; Issues related to access to healthcare; Issues related to COVID-19 Response; Issues related to Medicaid; Issues related to infrastructure; Issues related to health equity; Issues related to the implementation of the No Surprises Act; Issues related to Medicaid; Issues relating to the Presidents FY25 budget; Issues related to regulatory reform; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; S 717 Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; HR 6178 Increasing Access to Lung Cancer Screening Act; HR 6321 Lung Cancer Medicare Access to Precise Testing Act; HR 6320 Improving Medicaid Precision and Cancer Test Act of 2025","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"Issues related to tobacco use, lung cancer, lung disease treatment, prevention and research; and public health; Issues relating to the Presidents FY25 budget; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; Issues related to the Congressional Directed Medical Research Program; HR 4016 Department of Defense Appropriations Act, 2026; S 2572 Department of Defense Appropriations Act, 2026","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TOB","general_issue_code_display":"Tobacco","description":"Issues related to lung disease treatment, prevention and research; Issues related to tobacco cessation; Issues related to agency restructuring; Issues related to smokefree air; Issues related to the Tobacco Control Act; Issues related to tobacco smuggling; Issues related to the Affordable Care Act; Issues related to menthol cigarettes; Issues related to tobacco prevention; Issues related to youth cessation research; Issues related to nicotine; Issues related to health equity; Issues related to COVID-19 Response; Issues related to tobacco litter; Issues related to synthetic nicotine; Issues related to regulatory reform; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; S. 2171 A bill to amend title 38, united States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes; H.R. 4121 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026; S 2256 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026; HR 6844 The Tobacco Tracking, Reporting, and Accountability for Compliance in Enforcement Act; HR 6845 Strengthening Task Force Operations to Prevent Illicit Vaping Act; S 3569 Strengthening Task Force Operations to Prevent Illicit Vaping Act; Resources to Prevent Youth Vaping Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Issues related to taxes on tobacco products; Issues related to the Affordable Care Act; Issues related to COVID-19; Issues related to infrastructure; Issues relating to the Presidents FY25 budget; Issues relating to FY26 appropriations; S 317 Charitable Act; HR 801 Charitable Act; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":150198,"prefix":"mrs","prefix_display":"MRS.","first_name":"ELIZABETH","nickname":null,"middle_name":"ANNE MUELLER","last_name":"SCOTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"Issues related to lung disease treatment, prevention and research; Issues related to burn pits; Issues related to tobacco cessation; Issues related to smokefree air; Issues related to COVID-19 Response; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S. 2171 A bill to amend title 38, united States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/6120b9d2-352b-4762-bdb3-01e62c982226/","filing_uuid":"6120b9d2-352b-4762-bdb3-01e62c982226","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/6120b9d2-352b-4762-bdb3-01e62c982226/print/","filing_document_content_type":"text/html","income":null,"expenses":"600000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Cathleen Gates","dt_posted":"2026-04-20T15:43:45-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"2400 N Street, NW","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20037","registrant":{"id":1945,"url":"https://lda.gov/api/v1/registrants/1945/","house_registrant_id":30532,"name":"AMERICAN COLLEGE OF CARDIOLOGY","description":null,"address_1":"2400 N Street, NW","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20037","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"LUCAS SANDERS","contact_telephone":"+1 202-375-6397","dt_updated":"2026-07-29T12:01:27.325680-04:00"},"client":{"id":102667,"url":"https://lda.gov/api/v1/clients/102667/","client_id":12,"name":"AMERICAN COLLEGE OF CARDIOLOGY","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-09-28"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Health care quality; physician and hospital quality; health care innovation; Patient Protection and Affordable Care Act/health care reform implementation; unique device identifier policy and post-market surveillance for medical devices; clinical trial design; HIPAA and registries; federal funding/appropriations for HHS, NIH, AHRQ, CDC, FDA, HRSA and the Childrens Hospital Graduate Medical Education payment program, the Prevention & Public Health Fund, medical research, and prevention; research and scholarly communication policy; implementation and oversight of 21st Century Cures Act; data blocking/interoperability of electronic data; artificial intelligence/machine learning; algorithm transparency; health disparities; reduction/oversight of prior authorization and other administrative burdens; digital health; Sect. 1557 Nondiscrimination in Health Programs and Activities; cardiomyopathy education and awareness; peripheral arterial disease (PAD) education and awareness; VA Mission Act implementation; COVID-19 and implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act, the Families First Coronavirus Response Act , the Coronavirus Aid, Relief, and Economic Security Act, Coronavirus Provider Protection Act, and clinician mental health and wellbeing; patient identification; Pandemic and All Hazards Preparedness; MCIT/TCET/Breakthrough devices; Amputation Reduction and Compassion (ARC) Act (H.R. 307); Resident Education Deferred Interest (REDI) Act (H.R. 2028/S. 942); Implementation and funding for the Cardiomyopathy Health, Education, Awareness, Research and Training in Schools (HEARTS) Act (P.L. 118-176); provide AEDs in transportation facilities with the Public Access to Defibrillation in Transportation Facilities Act (H.R. 5897); Lorna Breen Health Care Provider Protection Reauthorization Act (H.R. 929/S. 266; Physician Led and Rural Access to Access to Quality Care Act (H.R. 2191/S. 1390); Section 232, National Security Investigation of Imports of Pharmaceuticals and Pharmaceutical Ingredients; and to protect health care workers from violence with the Save Healthcare Workers Act (H.R. 3178/S. 1600).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":139239,"prefix":"mr","prefix_display":"MR.","first_name":"NOIA","nickname":null,"middle_name":"NICHOLAS","last_name":"MORSE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":54728,"prefix":"mr","prefix_display":"MR.","first_name":"LUCAS","nickname":null,"middle_name":"ROBERT","last_name":"SANDERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70525,"prefix":null,"prefix_display":null,"first_name":"JOHNATHON","nickname":null,"middle_name":null,"last_name":"KRISTAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":54536,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"VAVRICEK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139515,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"MINNELLA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148563,"prefix":"ms","prefix_display":"MS.","first_name":"AMANDA","nickname":null,"middle_name":null,"last_name":"CAVALLO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143678,"prefix":"mr","prefix_display":"MR.","first_name":"FOSTER","nickname":null,"middle_name":"PATRICK","last_name":"CURRY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147772,"prefix":null,"prefix_display":null,"first_name":"ADRIENNE","nickname":null,"middle_name":null,"last_name":"MORTIMER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153653,"prefix":null,"prefix_display":null,"first_name":"FAIZAH","nickname":null,"middle_name":null,"last_name":"PIRZADA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":132,"name":"Agency for Healthcare Research & Quality (AHRQ)"},{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"The One Big Beautiful Bill Act, H.R. 1; Medicare physician payment including, the Medicare Patient Access and Practice Stabilization Act (H.R. 879); the Strengthening Medicare for Patients and Providers Act (H.R. 6160), the Provider Reimbursement Stability Act (S. 4935); the Provider Reimbursement Stability Act (H.R. 8163); and the Efficiency Adjustment Delay Act (H.R. 7520); new/alternative payment models; Medicare coverage, hospital payment of cardiovascular services; access to Medicare claims data; physician and hospital quality; Quality Payment Program; clinical data registries; health care quality; medical imaging and prior authorization; the Stark Law and the in-office ancillary services exception; Medicare Access and CHIP Reauthorization Act implementation and oversight; Bipartisan Budget Act of 2015 and Medicare site of service policy; graduate medical education policy including the Resident Physician Shortage Reduction Act (H.R. 3890/S. 2439); provide a specialty physician loan repayment program with the SPARC Act (H.R 4681/S. 1380); provide deferred interest payments for residents on student loans with the Resident Education Deferred Interest (REDI) Act (H.R. 2028/S. 942); oversight and implementation of the Protecting Access to Medicare Act of 2014, including Appropriate Use Criteria; physician-owned hospital policy including the Physician Led Rural Access to Quality Care Act (H.R. 2191/S. 1390) and the Patient Access to Higher Quality Health Care Act (H.R. 4002); COVID-19 public health emergency and the implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act, the Families First Coronavirus Response Act, the Coronavirus Aid, Relief, and Economic Security Act; implementation of the Protecting Medicare and American Farmers from Sequester Cuts Act; Increasing Access to Quality Cardiac Rehabilitation Care Act; the expansion of telehealth services, including the CONNECT for Health Act (H.R. 41894206/S. 1261), the Sustainable Cardiopulmonary Rehabilitation Services in the Home At (H.R. 783/S. 248), and the Telehealth Modernization Act (H.R. 5081/S. 2709); Improving maternal health, including Connected Maternal Online Monitoring Act (Connected MOM Act) (H.R. 4977/S. 141), Preventing Maternal Deaths Reauthorization Act of 2025 (H.R. 1909), and Rural Obstetrics Readiness Act (H.R. 1254/S. 380), and the Womens Heart Health Expansion Act (H.R. 7417/S. 3944) ; prior authorization reform, including the Improving Seniors Timely Access to Care Act (H.R. 3514/S. 1816), the Reducing Medically Unnecessary Delays in Care Act (H.R. 2433), and the Safe Step Act (H.R. 5509/S. 2903); clinician-led registry access to federal claims data, including the Access to Claims Data Act (H.R. 4331); and expanding in home prescribing coverage provided in the Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025 (H.R. 6894/S. 717), Centers for Medicare and Medicaid Innovation payment models.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":139239,"prefix":"mr","prefix_display":"MR.","first_name":"NOIA","nickname":null,"middle_name":"NICHOLAS","last_name":"MORSE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":54728,"prefix":"mr","prefix_display":"MR.","first_name":"LUCAS","nickname":null,"middle_name":"ROBERT","last_name":"SANDERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":54536,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"VAVRICEK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148568,"prefix":"ms","prefix_display":"MS.","first_name":"DEBRA","nickname":null,"middle_name":null,"last_name":"MARIANI-WEISSENBORN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70525,"prefix":null,"prefix_display":null,"first_name":"JOHNATHON","nickname":null,"middle_name":null,"last_name":"KRISTAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139515,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"MINNELLA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148563,"prefix":"ms","prefix_display":"MS.","first_name":"AMANDA","nickname":null,"middle_name":null,"last_name":"CAVALLO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143678,"prefix":"mr","prefix_display":"MR.","first_name":"FOSTER","nickname":null,"middle_name":"PATRICK","last_name":"CURRY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147772,"prefix":null,"prefix_display":null,"first_name":"ADRIENNE","nickname":null,"middle_name":null,"last_name":"MORTIMER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153653,"prefix":null,"prefix_display":null,"first_name":"FAIZAH","nickname":null,"middle_name":null,"last_name":"PIRZADA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":253,"name":"Medicare Payment Advisory Commission (MedPAC)"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TOB","general_issue_code_display":"Tobacco","description":"Tobacco use prevention and smoking cessation; FDA regulation of tobacco; electronic cigarettes and nicotine products; tobacco and electronic cigarette policy in House and Senate Appropriations; Federal funding for the CDCs Office of Smoking and Health and chronic disease prevention.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":139239,"prefix":"mr","prefix_display":"MR.","first_name":"NOIA","nickname":null,"middle_name":"NICHOLAS","last_name":"MORSE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":54728,"prefix":"mr","prefix_display":"MR.","first_name":"LUCAS","nickname":null,"middle_name":"ROBERT","last_name":"SANDERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70525,"prefix":null,"prefix_display":null,"first_name":"JOHNATHON","nickname":null,"middle_name":null,"last_name":"KRISTAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":54536,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"VAVRICEK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148563,"prefix":"ms","prefix_display":"MS.","first_name":"AMANDA","nickname":null,"middle_name":null,"last_name":"CAVALLO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143678,"prefix":"mr","prefix_display":"MR.","first_name":"FOSTER","nickname":null,"middle_name":"PATRICK","last_name":"CURRY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147772,"prefix":null,"prefix_display":null,"first_name":"ADRIENNE","nickname":null,"middle_name":null,"last_name":"MORTIMER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153653,"prefix":null,"prefix_display":null,"first_name":"FAIZAH","nickname":null,"middle_name":null,"last_name":"PIRZADA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/d4687345-1f63-4a38-9c36-9142082e810a/","filing_uuid":"d4687345-1f63-4a38-9c36-9142082e810a","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/d4687345-1f63-4a38-9c36-9142082e810a/print/","filing_document_content_type":"text/html","income":null,"expenses":"380000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Julie Stitzel","dt_posted":"2026-04-20T16:12:51-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"290 Harbor Drive","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Stamford","registrant_state":"CT","registrant_zip":"06902","registrant":{"id":401106760,"url":"https://lda.gov/api/v1/registrants/401106760/","house_registrant_id":45712,"name":"DIGITAL CURRENCY GROUP","description":null,"address_1":"262 Harbor Dr","address_2":null,"address_3":null,"address_4":null,"city":"Stamford","state":"CT","state_display":"Connecticut","zip":"06902","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JULIE STITZEL","contact_telephone":"+1 202-386-1259","dt_updated":"2026-07-20T14:39:02.223768-04:00"},"client":{"id":52614,"url":"https://lda.gov/api/v1/clients/52614/","client_id":52614,"name":"DIGITAL CURRENCY GROUP","general_description":"Support bitcoin & blockchain companies by leveraging insights, network & access to capital","client_government_entity":null,"client_self_select":true,"state":"CT","state_display":"Connecticut","country":"US","country_display":"United States of America","ppb_state":"CT","ppb_state_display":"Connecticut","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2022-07-01"},"lobbying_activities":[{"general_issue_code":"BAN","general_issue_code_display":"Banking","description":"General education around digital assets and decentralized AI S.875, FIRM Act S. 401, H.R. 987 Fair Access to Banking Act Legislation related to digital asset market structure legislation - HR 3633 (CLARITY Act) and the Responsible Financial Innovation Act of 2025. HR 1 (One Big Beautiful Bill Act) Issues related to the tax treatment of digital assets H.R.8149 - To amend the Internal Revenue Code of 1986 to clarify the tax treatment of digital asset rewards.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":139992,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"STITZEL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149565,"prefix":null,"prefix_display":null,"first_name":"TIFFANY","nickname":null,"middle_name":null,"last_name":"ANGULO","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"FIN","general_issue_code_display":"Financial Institutions/Investments/Securities","description":"General education around digital assets and decentralized AI To require the Secretary of the Treasury to develop a public-private partnership program with decentralized protocol developers and specialized auditing firms to examine embedded supervision and regulation of decentralized protocols, and for other purposes. H.R. 148, Keep Your Coins Act of 2025 S. 919, GENIUS Act H.R. 2392, STABLE Act H.R. 2384, Financial Technology Protection Act H.R.216, Securities Enforcement Clarity Act of 2025 H.R. 2365, Securities Clarity Act H.R.2032, BITCOIN Act H.Res.248, Resolution emphasizing the importance and power of distributed ledger technologies (DLT) to support democratic governance, human rights, internet freedom, and transparency. H.R. 1919, Anti-CBDC Surveillance State Act Legislation related to digital asset market structure legislation - HR 3633 (CLARITY Act) and the Responsible Financial Innovation Act of 2025. HR 1 (One Big Beautiful Bill Act) Issues related to the tax treatment of digital assets H.R.8149 - To amend the Internal Revenue Code of 1986 to clarify the tax treatment of digital asset rewards.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":139992,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"STITZEL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149565,"prefix":null,"prefix_display":null,"first_name":"TIFFANY","nickname":null,"middle_name":null,"last_name":"ANGULO","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"General education around digital assets and decentralized AI S.J. Res. 3, H.J. Res. 25 Resolution Disapproving Broker Rule Reconciliation/tax bill Legislation related to digital asset market structure legislation - HR 3633 (CLARITY Act) and the Responsible Financial Innovation Act of 2025. HR 1 (One Big Beautiful Bill Act) Issues related to the tax treatment of digital assets H.R.8149 - To amend the Internal Revenue Code of 1986 to clarify the tax treatment of digital asset rewards.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":139992,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"STITZEL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149565,"prefix":null,"prefix_display":null,"first_name":"TIFFANY","nickname":null,"middle_name":null,"last_name":"ANGULO","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"ENG","general_issue_code_display":"Energy/Nuclear","description":"General education around digital assets and decentralized AI Legislation related to digital asset market structure legislation - HR 3633 (CLARITY Act) and the Responsible Financial Innovation Act of 2025. HR 1 (One Big Beautiful Bill Act) Issues related to the tax treatment of digital assets H.R.8149 - To amend the Internal Revenue Code of 1986 to clarify the tax treatment of digital asset rewards.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":139992,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"STITZEL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149565,"prefix":null,"prefix_display":null,"first_name":"TIFFANY","nickname":null,"middle_name":null,"last_name":"ANGULO","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/c6fbfb56-bb76-4e83-a186-a704af68c957/","filing_uuid":"c6fbfb56-bb76-4e83-a186-a704af68c957","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/c6fbfb56-bb76-4e83-a186-a704af68c957/print/","filing_document_content_type":"text/html","income":null,"expenses":"30000.00","expenses_method":"B","expenses_method_display":"B","posted_by_name":"Kyle Zebley","dt_posted":"2026-07-15T08:59:50-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"601 13th St NW","registrant_address_2":"12th Floor","registrant_different_address":true,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":401106410,"url":"https://lda.gov/api/v1/registrants/401106410/","house_registrant_id":45477,"name":"ATA ACTION","description":null,"address_1":"601 13th St NW","address_2":"12th Floor","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"KYLE ZEBLEY","contact_telephone":"+1 412-760-8098","dt_updated":"2026-08-31T11:40:33.575220-04:00"},"client":{"id":50919,"url":"https://lda.gov/api/v1/clients/50919/","client_id":50919,"name":"ATA ACTION","general_description":"Trade organization advocating for telehealth","client_government_entity":null,"client_self_select":true,"state":"VA","state_display":"Virginia","country":"US","country_display":"United States of America","ppb_state":"VA","ppb_state_display":"Virginia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2022-01-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"ATA Action - Federal Legislative Priorities (119th Congress) As of Q4 2025, ATA Action continues to support and lobby for a broad portfolio of bipartisan legislation aimed at making telehealth and digital health a permanent, integrated part of care delivery in the U.S. healthcare system. Below is a summary of the legislation we are actively engaging on: 🔹 Top Legislative Priorities Telehealth Expansion Act (H.R. 1650 / S. 763) Sponsors: Rep. Arrington (R-TX), Rep. Susie Lee (D-NV), Sen. Daines (R-MT), Sen. Cortez Masto (D-NV) → Makes permanent the ability to offer pre-deductible telehealth services under high-deductible health plans linked to HSAs. Permanent Telehealth from Home Act (H.R. 1407) Sponsors: Rep. Buchanan (R-FL), Rep. Max Miller (R-OH), Rep. Mike Thompson (D-CA) → Eliminates originating site and geographic restrictions for Medicare telehealth services permanently. Audio-Only Telehealth Services Act (H.R. 1899) Sponsors: Rep. Feenstra (R-IA), Rep. Pappas (D-NH) → Makes permanent coverage of audio-only services in Medicare. Expanded Provider Access Act (H.R. 1614) Sponsors: Rep. Kelly (R-PA), Rep. Mike Thompson (D-CA) → Permits therapists, audiologists, and speech-language pathologists to deliver telehealth services permanently. TREATS Act (H.R. 1627) Sponsors: Rep. Norcross (D-NJ), Rep. Fitzpatrick (R-PA) → Permanently waives the in-person requirement for prescribing controlled substances (Schedules III-IV) via telehealth for substance use and opioid use disorders. 🔹 Additional Supported Legislation PREVENT DIABETES Act (H.R. 1523) Sponsors: Rep. DeGette (D-CO), Rep. Bilirakis (R-FL) → Expands Medicare Diabetes Prevention Program to include virtual suppliers. Sustainable Cardiopulmonary Rehabilitation in the Home Act (H.R. 783 / S. 248) Sponsors: Rep. Joyce (R-PA), Rep. Peters (D-CA), Sen. Blackburn (R-TN), Sen. Klobuchar (D-MN) → Makes permanent the option to provide cardiopulmonary rehab services at home via telehealth. Hospice Recertification Flexibility Act (H.R. 1720) Sponsors: Rep. Carol Miller (R-WV), Rep. Jared Golden (D-ME) → Allows hospice recertification visits via telehealth beyond 180 days. Rural Telehealth and Education Enhancement Act (H.R. 290) Sponsors: Rep. Langworthy (R-NY), Rep. Pingree (D-ME) → Reauthorizes USDAs Distance Learning and Telemedicine grant program through FY2030. ATA Action is actively advocating for these bills through direct engagement with congressional offices, testimony, coalition coordination, and public policy campaigns. This legislative portfolio reflects our commitment to securing permanent access to telehealth and integrating next-generation digital tools across care settings nationwide.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":139283,"prefix":"mr","prefix_display":"MR.","first_name":"KYLE","nickname":null,"middle_name":null,"last_name":"ZEBLEY","suffix":null,"suffix_display":null},"covered_position":"Legislative Director/Senior Legislative Assistant/Legislative Assistant, Rep. Tom Price (R-GA); Chief of Staff/Senior Advisor, HHS Office of the Secretary","new":false},{"lobbyist":{"id":154228,"prefix":null,"prefix_display":null,"first_name":"JOE","nickname":null,"middle_name":null,"last_name":"NYE","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"CONNECT for Health Act Reintroduction ATA Action strongly supports the Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act, the most comprehensive bipartisan telehealth legislation in Congress. The bill would permanently remove geographic and originating site restrictions, expand eligible providers, and allow patients to access care from their homes. It represents a critical step toward ensuring telehealth remains a foundational element of modern healthcare. Telehealth Modernization Act Reintroduction ATA Action endorses the Telehealth Modernization Act, which codifies the key Medicare telehealth flexibilities first introduced during the COVID-19 pandemic. The bill eliminates outdated site restrictions and empowers patients to receive care where and when they need it. This legislation is essential to maintaining progress and providing certainty to patients, providers, and health systems.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":139283,"prefix":"mr","prefix_display":"MR.","first_name":"KYLE","nickname":null,"middle_name":null,"last_name":"ZEBLEY","suffix":null,"suffix_display":null},"covered_position":"Legislative Director/Senior Legislative Assistant/Legislative Assistant, Rep. Tom Price (R-GA); Chief of Staff/Senior Advisor, HHS Office of the Secretary","new":false},{"lobbyist":{"id":138681,"prefix":null,"prefix_display":null,"first_name":"ALEXIS","nickname":null,"middle_name":"MARIA","last_name":"APPLE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/160bcf7b-4e3d-44cd-a84e-aebd8f84cda8/","filing_uuid":"160bcf7b-4e3d-44cd-a84e-aebd8f84cda8","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/160bcf7b-4e3d-44cd-a84e-aebd8f84cda8/print/","filing_document_content_type":"text/html","income":"20000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Matt McGinley","dt_posted":"2026-07-17T11:20:11-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"2503-D Harrison Street North #1210","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Arlington","registrant_state":"VA","registrant_zip":"22207","registrant":{"id":401103524,"url":"https://lda.gov/api/v1/registrants/401103524/","house_registrant_id":null,"name":"ADVANCED POLICY CONSULTING, LLC","description":"Consulting","address_1":"2503-D Harrison Street North #1210","address_2":null,"address_3":null,"address_4":null,"city":"Arlington","state":"VA","state_display":"Virginia","zip":"22207","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MATT MCGINLEY","contact_telephone":"+1 703-536-1705","dt_updated":"2026-07-24T11:29:57.639066-04:00"},"client":{"id":53847,"url":"https://lda.gov/api/v1/clients/53847/","client_id":53847,"name":"ATA ACTION","general_description":"Trade organization advocating for telehealth","client_government_entity":null,"client_self_select":false,"state":"VA","state_display":"Virginia","country":"US","country_display":"United States of America","ppb_state":"VA","ppb_state_display":"Virginia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2023-01-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Telehealth Expansion Act (H.R. 1650 / S. 763) Permanent Telehealth from Home Act (H.R. 1407) Audio-Only Telehealth Services Act (H.R. 1899) Expanded Provider Access Act (H.R. 1614) TREATS Act (H.R. 1627) PREVENT DIABETES Act (H.R. 1523) Sustainable Cardiopulmonary Rehabilitation in the Home Act (H.R. 783 / S. 248) Hospice Recertification Flexibility Act (H.R. 1720) Rural Telehealth and Education Enhancement Act (H.R. 290) Monitor Prescription Digital Therapeutics policy. H.R.6994 - To amend the Controlled Substances Act to modify requirements relating to the prescription of controlled substances by means of the Internet, and for other purposes.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":62356,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"MCGINLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":198,"name":"Natl Economic Council (NEC)"},{"id":19,"name":"Office of Natl Drug Control Policy (NDCP)"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"CONNECT for Health Act Reintroduction Telehealth Modernization Act Reintroduction Promote medicare Telehealth extension in government funding legislation.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":62356,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"MCGINLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":198,"name":"Natl Economic Council (NEC)"},{"id":19,"name":"Office of Natl Drug Control Policy (NDCP)"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/1abdef3a-602b-4a5b-99cf-dcc7e733436d/","filing_uuid":"1abdef3a-602b-4a5b-99cf-dcc7e733436d","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/1abdef3a-602b-4a5b-99cf-dcc7e733436d/print/","filing_document_content_type":"text/html","income":null,"expenses":"120000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Laura Katherine Bender","dt_posted":"2026-07-20T09:30:29-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"1331 Pennsylvania Ave NW","registrant_address_2":"Suite 1425 North","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":2811,"url":"https://lda.gov/api/v1/registrants/2811/","house_registrant_id":30549,"name":"AMERICAN LUNG ASSOCIATION","description":null,"address_1":"1331 Pennsylvania Ave NW","address_2":"Suite 1425 North","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"LAURA BENDER","contact_telephone":"+1 202-715-3457","dt_updated":"2026-07-20T09:13:00.293676-04:00"},"client":{"id":103597,"url":"https://lda.gov/api/v1/clients/103597/","client_id":12,"name":"AMERICAN LUNG ASSOCIATION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-02"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Issues related to lung disease treatment, prevention and research; public health; tobacco control and air pollution; Issues related to the Affordable Care Act; Issues related to COVID-19 Response; Issues related to infrastructure; Issues related to agency restructuring; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S 317 Charitable Act; HR 801 Charitable Act; Consolidated Appropriations Act, 2026; Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026; Breaking the Gridlock Act; HR 9171, Department of Interior, Environment and Related Agencies Appropriations Act, 207; HR 9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; HR 8646, Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027; S 4257, Resources to Prevent Youth Vaping Act; HR 9495, Department of Defense Appropriations Act, 2027","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150198,"prefix":"mrs","prefix_display":"MRS.","first_name":"ELIZABETH","nickname":null,"middle_name":"ANNE MUELLER","last_name":"SCOTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":49,"name":"Environmental Protection Agency (EPA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CAW","general_issue_code_display":"Clean Air and Water (quality)","description":"Issues related to the health impacts of air pollution and climate change; Issues related to air pollution from stationary and mobile sources; Issues related to the Clean Air Act; Issues related to California Clean Air Act waivers; Issues related to permitting and regulatory reforms; Issues related to infrastructure; Issues related to agency restructuring; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; Issues related to implementation of the Inflation Reduction Act; Issues related to appliance efficiency; issues related to prescribed burning;; S1072 Stop California from Advancing Regulatory Burden Act; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; HR 313 Natural Gas Tax Repeal Act; S 143 Natural Gas Tax Repeal Act; HR 471 Fix Our Forests; HJ Res 15/SJ Res 4 Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Energy relating to \"Energy Conservation Program: Energy Conservation Standards for Commercial Water Heating Equipment\"; HR 903/S 341 Smoke and Heat Ready Communities Act; S 541 Eliminating Lavish Incentives to Electric Vehicles Act; HR 1449 Energy Resilient Communities Act;; S 711 Transportation Freedom Act; HR 1651 To nullify the final rule issued by the Environmental Protection Agency relating to \"New Source Performance Standards for Greenhouse Gas Emissions From New, Modified, and Reconstructed Fossil Fuel-Fired Electric Generating Units; Emission Guidelines for Greenhouse Gas Emissions From Existing Fossil Fuel-Fired Electric Generating Units; and Repeal of the Affordable Clean Energy Rule\"; HR 1415/S 623 No Industrial Restrictions In Secret (No IRIS) Act; HR 2140 DERA Act 2025; S 1072 A bill to amend the Clean Air Act to eliminate a waiver under that Act, to eliminate an authorization for States to use new motor vehicle emission and new motor vehicle engine emissions standards identical to standards adopted in California, and for other purposes; HR 2165 Choice in Automobile Retail Sales (CARS) Act; HR 346 Preserving Choice in Vehicle Purchases Act; S 990 Freedom to Haul Act; HR 2288 To nullify the final rule of the Environmental Protection Agency titled \"Reconsideration of the National Ambient Air Quality Standards for Particulate Matter\"; ; HJ Res 30/SJ Res 14 Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"Phasedown of Hydrofluorocarbons: Management of Certain Hydrofluorocarbons and Substitutes Under the American Innovation and Manufacturing Act of 2020\"; S 1166 Excess Urban Heat Mitigation Act; HR 4214 To require the Administrator of the Environmental Protection Agency to publish, concurrently with any final rule establishing or revising a national ambient air quality standard, regulations and guidance for implementing the standard, including information relating to submission and consideration of a preconstruction permit application under the new or revised standard, and for other purposes; HR 3889/S 2015 National Prescribed Fire Act; H.Res. 585 Recognizing the threat of extreme weather to childrens health and wellbeing, and expressing the sense of Congress that solutions must be rapidly and equitably developed and deployed to address the unique vulnerabilities and needs of children; HR 4443/S 2298 Asuncion Valdivia Heat Illness, Injury, and Fatality Prevention Act; S 2340/HR 4515 Climate Change Health Protection and Promotion Act of 2025; HR 4744/S 2445 Community Mental Wellness and Resilience Act; HR 161 New Source Review Permitting Improvement Act; HR HR 6387 Fire Improvement and Reforming Exceptional Events Act; HR 6409 Foreign Emissions and Nonattainment Clarification for Economic Stability Act; HR 6398 Reducing and Eliminating Duplicative Environmental Regulations Act; HR 6373 Air Permitting Improvements to Protect National Security Act; H.R. 4214 Clean Air and Building Infrastructure Improvement Act;; S 2431 Department of the Interior, Environment, and Related Agencies Appropriations Act, 2026; HR 4754 Department of the Interior, Environment, and Related Agencies Appropriations Act, 2026; HR 4553 Energy and Water Development and Related Agencies Appropriations Act, 2026; HR 4776 SPEED Act; S 3529 Public Health Air Quality Act; S 3007, Diesel Truck Liberation Act; S 237 Honoring Our Fallen Heroes Act; Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026; Protection of Lawful Commerce in Stone Slab Products Act; Home Appliance Protection and Affordability Act; Homeowner Energy Freedom Act; Energy Bills Relief Act; Promoting Reduction of Emissions through Landscaping Act; Discussion Draft of Legislation to Modernize the Toxic Substances Control Act ; SHOWER Act; Affordable HOMES Act; HR 4690, Reliable Federal Infrastructure Act; HR 2165, Choice in Automobile Retail Sales Act; HR 3194, LOCOMOTIVES Act; HR 6200, ESSENTIAL Act; HR 6250, Cold Weather Diesel Reliability Act; HR 7000, Freedom to Fuel Act; HR 8782, PLOW Storms Act; HR 2140, Diesel Emissions Reduction Act of 2025; HR 8870, Build America 250 Act; HR 9022, Fiscal Year 2027 Energy and Water Appropriations Bill; S 4732, Wildfire Smoke Emergency Declaration Act; HR 9243, Wildfire Smoke Emergency Declaration Act; HR 9453, End EPA Abuse Act; S 4931, End EPA Abuse Act; HR 9171, Department of Interior, Environment and Related Agencies Appropriations Act, 207; HR 9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; HR 9170, Transportation, Housing and Urban Development and Related Agencies Appropriations Act, 2027; HR 6387, Fire Improvement and Reforming Exceptional Events Act; HR 6409, Foreign Emissions and Nonattainment Clarification for Economic Stability Act; HR 9317, Buses Utilizing Safety and Environmental Standards Act; HR 9618, Diesel Engine Flexibility Act; HR 1346, To amend the Clean Air Act with respect to the ethanol waiver for Reid Vapor Pressure under that Act, and for other purposes; S 4404, No Passes for Polluters Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":150198,"prefix":"mrs","prefix_display":"MRS.","first_name":"ELIZABETH","nickname":null,"middle_name":"ANNE MUELLER","last_name":"SCOTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":33,"name":"Energy, Dept of"},{"id":49,"name":"Environmental Protection Agency (EPA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":36,"name":"Interior, Dept of (DOI)"},{"id":188,"name":"Internal Revenue Service (IRS)"},{"id":175,"name":"Natl Highway Traffic Safety Administration (NHTSA)"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"},{"id":40,"name":"Transportation, Dept of (DOT)"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to lung disease treatment, prevention and research; Issues related to public health; Issues related asthma, COPD, influenza, lung cancer, pneumonia, pulmonary fibrosis, tuberculosis and other lung diseases; Issues related to tobacco cessation; Issues related to the Affordable Care Act; Issues related to agency restructuring; Issues related to the Childrens Health Insurance Program; Issues related to Medicaid; Issues related to ERISA; Issues related to COVID-19 Response; Issues related to vaccines; Issues related to infrastructure; Issues related to supplemental oxygen; Issues related to the implementation of the No Surprises Act; Issues related to Medicare sequestration; Issues related to Cancer Moonshot; Issues related to short-term limited duration plans; Issues related to Healthy Future Taskforce; Issues related to regulatory reform; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 717Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; H.R. 3701 Family Vaccine Protection Act; H.R. 3521 Clinical Trial Modernization Act;;; HR 4417 Mobile Cancer Screening Act HR 3701 Family Vaccine Protection Act; HR 5304Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; S 2587 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; HR 5278/S 2756 Affordable Inhalers and Nebulizers Act of 2025; HR 6703 Lower Health Care Premiums for All Americans Act; S 2466 Senior Savings Protection Act; HR Senior Savings Protection Act; HR 6052 Elijah E. Cummings Family Asthma Act; HR 6319 Benay Taub Lung Cancer Research Act; HR 45448 Protecting Free Vaccines Act; Consolidated Appropriations Act, 2026; Breaking the Gridlock Act; HR 9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Issues relating to FY25 appropriations; Issues relating to the Presidents FY26 budget; Issues related to asthma, COPD, influenza, lung cancer, pneumonia, pulmonary fibrosis, tuberculosis and other lung diseases; Issues related to NIH reorganization; Issues related to agency restructuring; Issues related to lung disease treatment, prevention and research; Issues related to COVID-19; Issues related to telehealth; Issues related to infrastructure; Issues related to supplemental oxygen; Issues related to health equity; Issues related to Cancer Moonshot; Issues related to CDC public health workforce and data modernization; Issues related to regulatory reform; Issues related to Medicaid; H.R. 1509/S. 752, the Accelerating Kids Access to Care Act; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 717 Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; H.R. 3521 Clinical Trial Modernization Act; ;; HR 4417 Mobile Cancer Screening Act; HR 5304 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; S 2587 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; HR 5278/S 2756 Affordable Inhalers and Nebulizers Act of 2025; HR 45448 Protecting Free Vaccines Act; HR 9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to lung disease treatment, prevention and research; Issues related to public health; Issues related to tobacco cessation; Issues related to health inequities; Issues related to Medicaid waivers; Issues related to agency restructuring; Issues related to the Affordable Care Act; Issues related to supplemental oxygen; Issues related to access to healthcare; Issues related to COVID-19 Response; Issues related to Medicaid; Issues related to infrastructure; Issues related to health equity; Issues related to the implementation of the No Surprises Act; Issues related to Medicaid; Issues relating to the Presidents FY25 budget; Issues related to regulatory reform; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; S 717 Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; HR 6178 Increasing Access to Lung Cancer Screening Act; HR 6321 Lung Cancer Medicare Access to Precise Testing Act; HR 6320 Improving Medicaid Precision and Cancer Test Act of 2025; Consolidated Appropriations Act, 2026; HR 8839, Lanie Jones Comprehensive Cancer Survivorship Act of 2026; S. 4566, Increasing Access to Lung Cancer Screening Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"Issues related to tobacco use, lung cancer, lung disease treatment, prevention and research; and public health; Issues relating to the Presidents FY25 budget; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; Issues related to the Congressional Directed Medical Research Program;; HR 4016 Department of Defense Appropriations Act, 2026; S 2572 Department of Defense Appropriations Act, 2026; HR 9495, Department of Defense Appropriations Act, 2027","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TOB","general_issue_code_display":"Tobacco","description":"Issues related to lung disease treatment, prevention and research; Issues related to tobacco cessation; Issues related to agency restructuring; Issues related to smokefree air; Issues related to the Tobacco Control Act; Issues related to tobacco smuggling; Issues related to the Affordable Care Act; Issues related to menthol cigarettes; Issues related to tobacco prevention; Issues related to youth cessation research; Issues related to nicotine; Issues related to health equity; Issues related to COVID-19 Response; Issues related to tobacco litter; Issues related to synthetic nicotine; Issues related to regulatory reform; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; S. 2171 A bill to amend title 38, united States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes; H.R. 4121 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026; S 2256 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026; HR 6844 The Tobacco Tracking, Reporting, and Accountability for Compliance in Enforcement Act; HR 6845 Strengthening Task Force Operations to Prevent Illicit Vaping Act; S 3569 Strengthening Task Force Operations to Prevent Illicit Vaping Act; HR 8646, Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027; S 4257, Resources to Prevent Youth Vaping Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Issues related to taxes on tobacco products; Issues related to the Affordable Care Act; Issues related to COVID-19; Issues related to infrastructure; Issues relating to the Presidents FY25 budget; Issues relating to FY26 appropriations; S 317 Charitable Act; HR 801 Charitable Act; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":150198,"prefix":"mrs","prefix_display":"MRS.","first_name":"ELIZABETH","nickname":null,"middle_name":"ANNE MUELLER","last_name":"SCOTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"Issues related to lung disease treatment, prevention and research; Issues related to burn pits; Issues related to tobacco cessation; Issues related to smokefree air; Issues related to COVID-19 Response; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S. 2171 A bill to amend title 38, united States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/1abdef3a-602b-4a5b-99cf-dcc7e733436d/","filing_uuid":"1abdef3a-602b-4a5b-99cf-dcc7e733436d","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/1abdef3a-602b-4a5b-99cf-dcc7e733436d/print/","filing_document_content_type":"text/html","income":null,"expenses":"120000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Laura Katherine Bender","dt_posted":"2026-07-20T09:30:29-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"1331 Pennsylvania Ave NW","registrant_address_2":"Suite 1425 North","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":2811,"url":"https://lda.gov/api/v1/registrants/2811/","house_registrant_id":30549,"name":"AMERICAN LUNG ASSOCIATION","description":null,"address_1":"1331 Pennsylvania Ave NW","address_2":"Suite 1425 North","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"LAURA BENDER","contact_telephone":"+1 202-715-3457","dt_updated":"2026-07-20T09:13:00.293676-04:00"},"client":{"id":103597,"url":"https://lda.gov/api/v1/clients/103597/","client_id":12,"name":"AMERICAN LUNG ASSOCIATION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-02"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Issues related to lung disease treatment, prevention and research; public health; tobacco control and air pollution; Issues related to the Affordable Care Act; Issues related to COVID-19 Response; Issues related to infrastructure; Issues related to agency restructuring; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S 317 Charitable Act; HR 801 Charitable Act; Consolidated Appropriations Act, 2026; Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026; Breaking the Gridlock Act; HR 9171, Department of Interior, Environment and Related Agencies Appropriations Act, 207; HR 9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; HR 8646, Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027; S 4257, Resources to Prevent Youth Vaping Act; HR 9495, Department of Defense Appropriations Act, 2027","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150198,"prefix":"mrs","prefix_display":"MRS.","first_name":"ELIZABETH","nickname":null,"middle_name":"ANNE MUELLER","last_name":"SCOTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":49,"name":"Environmental Protection Agency (EPA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CAW","general_issue_code_display":"Clean Air and Water (quality)","description":"Issues related to the health impacts of air pollution and climate change; Issues related to air pollution from stationary and mobile sources; Issues related to the Clean Air Act; Issues related to California Clean Air Act waivers; Issues related to permitting and regulatory reforms; Issues related to infrastructure; Issues related to agency restructuring; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; Issues related to implementation of the Inflation Reduction Act; Issues related to appliance efficiency; issues related to prescribed burning;; S1072 Stop California from Advancing Regulatory Burden Act; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; HR 313 Natural Gas Tax Repeal Act; S 143 Natural Gas Tax Repeal Act; HR 471 Fix Our Forests; HJ Res 15/SJ Res 4 Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Energy relating to \"Energy Conservation Program: Energy Conservation Standards for Commercial Water Heating Equipment\"; HR 903/S 341 Smoke and Heat Ready Communities Act; S 541 Eliminating Lavish Incentives to Electric Vehicles Act; HR 1449 Energy Resilient Communities Act;; S 711 Transportation Freedom Act; HR 1651 To nullify the final rule issued by the Environmental Protection Agency relating to \"New Source Performance Standards for Greenhouse Gas Emissions From New, Modified, and Reconstructed Fossil Fuel-Fired Electric Generating Units; Emission Guidelines for Greenhouse Gas Emissions From Existing Fossil Fuel-Fired Electric Generating Units; and Repeal of the Affordable Clean Energy Rule\"; HR 1415/S 623 No Industrial Restrictions In Secret (No IRIS) Act; HR 2140 DERA Act 2025; S 1072 A bill to amend the Clean Air Act to eliminate a waiver under that Act, to eliminate an authorization for States to use new motor vehicle emission and new motor vehicle engine emissions standards identical to standards adopted in California, and for other purposes; HR 2165 Choice in Automobile Retail Sales (CARS) Act; HR 346 Preserving Choice in Vehicle Purchases Act; S 990 Freedom to Haul Act; HR 2288 To nullify the final rule of the Environmental Protection Agency titled \"Reconsideration of the National Ambient Air Quality Standards for Particulate Matter\"; ; HJ Res 30/SJ Res 14 Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"Phasedown of Hydrofluorocarbons: Management of Certain Hydrofluorocarbons and Substitutes Under the American Innovation and Manufacturing Act of 2020\"; S 1166 Excess Urban Heat Mitigation Act; HR 4214 To require the Administrator of the Environmental Protection Agency to publish, concurrently with any final rule establishing or revising a national ambient air quality standard, regulations and guidance for implementing the standard, including information relating to submission and consideration of a preconstruction permit application under the new or revised standard, and for other purposes; HR 3889/S 2015 National Prescribed Fire Act; H.Res. 585 Recognizing the threat of extreme weather to childrens health and wellbeing, and expressing the sense of Congress that solutions must be rapidly and equitably developed and deployed to address the unique vulnerabilities and needs of children; HR 4443/S 2298 Asuncion Valdivia Heat Illness, Injury, and Fatality Prevention Act; S 2340/HR 4515 Climate Change Health Protection and Promotion Act of 2025; HR 4744/S 2445 Community Mental Wellness and Resilience Act; HR 161 New Source Review Permitting Improvement Act; HR HR 6387 Fire Improvement and Reforming Exceptional Events Act; HR 6409 Foreign Emissions and Nonattainment Clarification for Economic Stability Act; HR 6398 Reducing and Eliminating Duplicative Environmental Regulations Act; HR 6373 Air Permitting Improvements to Protect National Security Act; H.R. 4214 Clean Air and Building Infrastructure Improvement Act;; S 2431 Department of the Interior, Environment, and Related Agencies Appropriations Act, 2026; HR 4754 Department of the Interior, Environment, and Related Agencies Appropriations Act, 2026; HR 4553 Energy and Water Development and Related Agencies Appropriations Act, 2026; HR 4776 SPEED Act; S 3529 Public Health Air Quality Act; S 3007, Diesel Truck Liberation Act; S 237 Honoring Our Fallen Heroes Act; Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026; Protection of Lawful Commerce in Stone Slab Products Act; Home Appliance Protection and Affordability Act; Homeowner Energy Freedom Act; Energy Bills Relief Act; Promoting Reduction of Emissions through Landscaping Act; Discussion Draft of Legislation to Modernize the Toxic Substances Control Act ; SHOWER Act; Affordable HOMES Act; HR 4690, Reliable Federal Infrastructure Act; HR 2165, Choice in Automobile Retail Sales Act; HR 3194, LOCOMOTIVES Act; HR 6200, ESSENTIAL Act; HR 6250, Cold Weather Diesel Reliability Act; HR 7000, Freedom to Fuel Act; HR 8782, PLOW Storms Act; HR 2140, Diesel Emissions Reduction Act of 2025; HR 8870, Build America 250 Act; HR 9022, Fiscal Year 2027 Energy and Water Appropriations Bill; S 4732, Wildfire Smoke Emergency Declaration Act; HR 9243, Wildfire Smoke Emergency Declaration Act; HR 9453, End EPA Abuse Act; S 4931, End EPA Abuse Act; HR 9171, Department of Interior, Environment and Related Agencies Appropriations Act, 207; HR 9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; HR 9170, Transportation, Housing and Urban Development and Related Agencies Appropriations Act, 2027; HR 6387, Fire Improvement and Reforming Exceptional Events Act; HR 6409, Foreign Emissions and Nonattainment Clarification for Economic Stability Act; HR 9317, Buses Utilizing Safety and Environmental Standards Act; HR 9618, Diesel Engine Flexibility Act; HR 1346, To amend the Clean Air Act with respect to the ethanol waiver for Reid Vapor Pressure under that Act, and for other purposes; S 4404, No Passes for Polluters Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":150198,"prefix":"mrs","prefix_display":"MRS.","first_name":"ELIZABETH","nickname":null,"middle_name":"ANNE MUELLER","last_name":"SCOTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":33,"name":"Energy, Dept of"},{"id":49,"name":"Environmental Protection Agency (EPA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":36,"name":"Interior, Dept of (DOI)"},{"id":188,"name":"Internal Revenue Service (IRS)"},{"id":175,"name":"Natl Highway Traffic Safety Administration (NHTSA)"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"},{"id":40,"name":"Transportation, Dept of (DOT)"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to lung disease treatment, prevention and research; Issues related to public health; Issues related asthma, COPD, influenza, lung cancer, pneumonia, pulmonary fibrosis, tuberculosis and other lung diseases; Issues related to tobacco cessation; Issues related to the Affordable Care Act; Issues related to agency restructuring; Issues related to the Childrens Health Insurance Program; Issues related to Medicaid; Issues related to ERISA; Issues related to COVID-19 Response; Issues related to vaccines; Issues related to infrastructure; Issues related to supplemental oxygen; Issues related to the implementation of the No Surprises Act; Issues related to Medicare sequestration; Issues related to Cancer Moonshot; Issues related to short-term limited duration plans; Issues related to Healthy Future Taskforce; Issues related to regulatory reform; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 717Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; H.R. 3701 Family Vaccine Protection Act; H.R. 3521 Clinical Trial Modernization Act;;; HR 4417 Mobile Cancer Screening Act HR 3701 Family Vaccine Protection Act; HR 5304Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; S 2587 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; HR 5278/S 2756 Affordable Inhalers and Nebulizers Act of 2025; HR 6703 Lower Health Care Premiums for All Americans Act; S 2466 Senior Savings Protection Act; HR Senior Savings Protection Act; HR 6052 Elijah E. Cummings Family Asthma Act; HR 6319 Benay Taub Lung Cancer Research Act; HR 45448 Protecting Free Vaccines Act; Consolidated Appropriations Act, 2026; Breaking the Gridlock Act; HR 9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Issues relating to FY25 appropriations; Issues relating to the Presidents FY26 budget; Issues related to asthma, COPD, influenza, lung cancer, pneumonia, pulmonary fibrosis, tuberculosis and other lung diseases; Issues related to NIH reorganization; Issues related to agency restructuring; Issues related to lung disease treatment, prevention and research; Issues related to COVID-19; Issues related to telehealth; Issues related to infrastructure; Issues related to supplemental oxygen; Issues related to health equity; Issues related to Cancer Moonshot; Issues related to CDC public health workforce and data modernization; Issues related to regulatory reform; Issues related to Medicaid; H.R. 1509/S. 752, the Accelerating Kids Access to Care Act; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 717 Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; H.R. 3521 Clinical Trial Modernization Act; ;; HR 4417 Mobile Cancer Screening Act; HR 5304 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; S 2587 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; HR 5278/S 2756 Affordable Inhalers and Nebulizers Act of 2025; HR 45448 Protecting Free Vaccines Act; HR 9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to lung disease treatment, prevention and research; Issues related to public health; Issues related to tobacco cessation; Issues related to health inequities; Issues related to Medicaid waivers; Issues related to agency restructuring; Issues related to the Affordable Care Act; Issues related to supplemental oxygen; Issues related to access to healthcare; Issues related to COVID-19 Response; Issues related to Medicaid; Issues related to infrastructure; Issues related to health equity; Issues related to the implementation of the No Surprises Act; Issues related to Medicaid; Issues relating to the Presidents FY25 budget; Issues related to regulatory reform; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; S 717 Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; HR 6178 Increasing Access to Lung Cancer Screening Act; HR 6321 Lung Cancer Medicare Access to Precise Testing Act; HR 6320 Improving Medicaid Precision and Cancer Test Act of 2025; Consolidated Appropriations Act, 2026; HR 8839, Lanie Jones Comprehensive Cancer Survivorship Act of 2026; S. 4566, Increasing Access to Lung Cancer Screening Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"Issues related to tobacco use, lung cancer, lung disease treatment, prevention and research; and public health; Issues relating to the Presidents FY25 budget; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; Issues related to the Congressional Directed Medical Research Program;; HR 4016 Department of Defense Appropriations Act, 2026; S 2572 Department of Defense Appropriations Act, 2026; HR 9495, Department of Defense Appropriations Act, 2027","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TOB","general_issue_code_display":"Tobacco","description":"Issues related to lung disease treatment, prevention and research; Issues related to tobacco cessation; Issues related to agency restructuring; Issues related to smokefree air; Issues related to the Tobacco Control Act; Issues related to tobacco smuggling; Issues related to the Affordable Care Act; Issues related to menthol cigarettes; Issues related to tobacco prevention; Issues related to youth cessation research; Issues related to nicotine; Issues related to health equity; Issues related to COVID-19 Response; Issues related to tobacco litter; Issues related to synthetic nicotine; Issues related to regulatory reform; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; S. 2171 A bill to amend title 38, united States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes; H.R. 4121 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026; S 2256 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026; HR 6844 The Tobacco Tracking, Reporting, and Accountability for Compliance in Enforcement Act; HR 6845 Strengthening Task Force Operations to Prevent Illicit Vaping Act; S 3569 Strengthening Task Force Operations to Prevent Illicit Vaping Act; HR 8646, Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027; S 4257, Resources to Prevent Youth Vaping Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Issues related to taxes on tobacco products; Issues related to the Affordable Care Act; Issues related to COVID-19; Issues related to infrastructure; Issues relating to the Presidents FY25 budget; Issues relating to FY26 appropriations; S 317 Charitable Act; HR 801 Charitable Act; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":150198,"prefix":"mrs","prefix_display":"MRS.","first_name":"ELIZABETH","nickname":null,"middle_name":"ANNE MUELLER","last_name":"SCOTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"Issues related to lung disease treatment, prevention and research; Issues related to burn pits; Issues related to tobacco cessation; Issues related to smokefree air; Issues related to COVID-19 Response; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S. 2171 A bill to amend title 38, united States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/1abdef3a-602b-4a5b-99cf-dcc7e733436d/","filing_uuid":"1abdef3a-602b-4a5b-99cf-dcc7e733436d","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/1abdef3a-602b-4a5b-99cf-dcc7e733436d/print/","filing_document_content_type":"text/html","income":null,"expenses":"120000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Laura Katherine Bender","dt_posted":"2026-07-20T09:30:29-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"1331 Pennsylvania Ave NW","registrant_address_2":"Suite 1425 North","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":2811,"url":"https://lda.gov/api/v1/registrants/2811/","house_registrant_id":30549,"name":"AMERICAN LUNG ASSOCIATION","description":null,"address_1":"1331 Pennsylvania Ave NW","address_2":"Suite 1425 North","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"LAURA BENDER","contact_telephone":"+1 202-715-3457","dt_updated":"2026-07-20T09:13:00.293676-04:00"},"client":{"id":103597,"url":"https://lda.gov/api/v1/clients/103597/","client_id":12,"name":"AMERICAN LUNG ASSOCIATION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-02"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Issues related to lung disease treatment, prevention and research; public health; tobacco control and air pollution; Issues related to the Affordable Care Act; Issues related to COVID-19 Response; Issues related to infrastructure; Issues related to agency restructuring; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S 317 Charitable Act; HR 801 Charitable Act; Consolidated Appropriations Act, 2026; Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026; Breaking the Gridlock Act; HR 9171, Department of Interior, Environment and Related Agencies Appropriations Act, 207; HR 9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; HR 8646, Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027; S 4257, Resources to Prevent Youth Vaping Act; HR 9495, Department of Defense Appropriations Act, 2027","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150198,"prefix":"mrs","prefix_display":"MRS.","first_name":"ELIZABETH","nickname":null,"middle_name":"ANNE MUELLER","last_name":"SCOTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":49,"name":"Environmental Protection Agency (EPA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CAW","general_issue_code_display":"Clean Air and Water (quality)","description":"Issues related to the health impacts of air pollution and climate change; Issues related to air pollution from stationary and mobile sources; Issues related to the Clean Air Act; Issues related to California Clean Air Act waivers; Issues related to permitting and regulatory reforms; Issues related to infrastructure; Issues related to agency restructuring; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; Issues related to implementation of the Inflation Reduction Act; Issues related to appliance efficiency; issues related to prescribed burning;; S1072 Stop California from Advancing Regulatory Burden Act; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; HR 313 Natural Gas Tax Repeal Act; S 143 Natural Gas Tax Repeal Act; HR 471 Fix Our Forests; HJ Res 15/SJ Res 4 Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Energy relating to \"Energy Conservation Program: Energy Conservation Standards for Commercial Water Heating Equipment\"; HR 903/S 341 Smoke and Heat Ready Communities Act; S 541 Eliminating Lavish Incentives to Electric Vehicles Act; HR 1449 Energy Resilient Communities Act;; S 711 Transportation Freedom Act; HR 1651 To nullify the final rule issued by the Environmental Protection Agency relating to \"New Source Performance Standards for Greenhouse Gas Emissions From New, Modified, and Reconstructed Fossil Fuel-Fired Electric Generating Units; Emission Guidelines for Greenhouse Gas Emissions From Existing Fossil Fuel-Fired Electric Generating Units; and Repeal of the Affordable Clean Energy Rule\"; HR 1415/S 623 No Industrial Restrictions In Secret (No IRIS) Act; HR 2140 DERA Act 2025; S 1072 A bill to amend the Clean Air Act to eliminate a waiver under that Act, to eliminate an authorization for States to use new motor vehicle emission and new motor vehicle engine emissions standards identical to standards adopted in California, and for other purposes; HR 2165 Choice in Automobile Retail Sales (CARS) Act; HR 346 Preserving Choice in Vehicle Purchases Act; S 990 Freedom to Haul Act; HR 2288 To nullify the final rule of the Environmental Protection Agency titled \"Reconsideration of the National Ambient Air Quality Standards for Particulate Matter\"; ; HJ Res 30/SJ Res 14 Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"Phasedown of Hydrofluorocarbons: Management of Certain Hydrofluorocarbons and Substitutes Under the American Innovation and Manufacturing Act of 2020\"; S 1166 Excess Urban Heat Mitigation Act; HR 4214 To require the Administrator of the Environmental Protection Agency to publish, concurrently with any final rule establishing or revising a national ambient air quality standard, regulations and guidance for implementing the standard, including information relating to submission and consideration of a preconstruction permit application under the new or revised standard, and for other purposes; HR 3889/S 2015 National Prescribed Fire Act; H.Res. 585 Recognizing the threat of extreme weather to childrens health and wellbeing, and expressing the sense of Congress that solutions must be rapidly and equitably developed and deployed to address the unique vulnerabilities and needs of children; HR 4443/S 2298 Asuncion Valdivia Heat Illness, Injury, and Fatality Prevention Act; S 2340/HR 4515 Climate Change Health Protection and Promotion Act of 2025; HR 4744/S 2445 Community Mental Wellness and Resilience Act; HR 161 New Source Review Permitting Improvement Act; HR HR 6387 Fire Improvement and Reforming Exceptional Events Act; HR 6409 Foreign Emissions and Nonattainment Clarification for Economic Stability Act; HR 6398 Reducing and Eliminating Duplicative Environmental Regulations Act; HR 6373 Air Permitting Improvements to Protect National Security Act; H.R. 4214 Clean Air and Building Infrastructure Improvement Act;; S 2431 Department of the Interior, Environment, and Related Agencies Appropriations Act, 2026; HR 4754 Department of the Interior, Environment, and Related Agencies Appropriations Act, 2026; HR 4553 Energy and Water Development and Related Agencies Appropriations Act, 2026; HR 4776 SPEED Act; S 3529 Public Health Air Quality Act; S 3007, Diesel Truck Liberation Act; S 237 Honoring Our Fallen Heroes Act; Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026; Protection of Lawful Commerce in Stone Slab Products Act; Home Appliance Protection and Affordability Act; Homeowner Energy Freedom Act; Energy Bills Relief Act; Promoting Reduction of Emissions through Landscaping Act; Discussion Draft of Legislation to Modernize the Toxic Substances Control Act ; SHOWER Act; Affordable HOMES Act; HR 4690, Reliable Federal Infrastructure Act; HR 2165, Choice in Automobile Retail Sales Act; HR 3194, LOCOMOTIVES Act; HR 6200, ESSENTIAL Act; HR 6250, Cold Weather Diesel Reliability Act; HR 7000, Freedom to Fuel Act; HR 8782, PLOW Storms Act; HR 2140, Diesel Emissions Reduction Act of 2025; HR 8870, Build America 250 Act; HR 9022, Fiscal Year 2027 Energy and Water Appropriations Bill; S 4732, Wildfire Smoke Emergency Declaration Act; HR 9243, Wildfire Smoke Emergency Declaration Act; HR 9453, End EPA Abuse Act; S 4931, End EPA Abuse Act; HR 9171, Department of Interior, Environment and Related Agencies Appropriations Act, 207; HR 9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; HR 9170, Transportation, Housing and Urban Development and Related Agencies Appropriations Act, 2027; HR 6387, Fire Improvement and Reforming Exceptional Events Act; HR 6409, Foreign Emissions and Nonattainment Clarification for Economic Stability Act; HR 9317, Buses Utilizing Safety and Environmental Standards Act; HR 9618, Diesel Engine Flexibility Act; HR 1346, To amend the Clean Air Act with respect to the ethanol waiver for Reid Vapor Pressure under that Act, and for other purposes; S 4404, No Passes for Polluters Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":150198,"prefix":"mrs","prefix_display":"MRS.","first_name":"ELIZABETH","nickname":null,"middle_name":"ANNE MUELLER","last_name":"SCOTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":33,"name":"Energy, Dept of"},{"id":49,"name":"Environmental Protection Agency (EPA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":36,"name":"Interior, Dept of (DOI)"},{"id":188,"name":"Internal Revenue Service (IRS)"},{"id":175,"name":"Natl Highway Traffic Safety Administration (NHTSA)"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"},{"id":40,"name":"Transportation, Dept of (DOT)"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to lung disease treatment, prevention and research; Issues related to public health; Issues related asthma, COPD, influenza, lung cancer, pneumonia, pulmonary fibrosis, tuberculosis and other lung diseases; Issues related to tobacco cessation; Issues related to the Affordable Care Act; Issues related to agency restructuring; Issues related to the Childrens Health Insurance Program; Issues related to Medicaid; Issues related to ERISA; Issues related to COVID-19 Response; Issues related to vaccines; Issues related to infrastructure; Issues related to supplemental oxygen; Issues related to the implementation of the No Surprises Act; Issues related to Medicare sequestration; Issues related to Cancer Moonshot; Issues related to short-term limited duration plans; Issues related to Healthy Future Taskforce; Issues related to regulatory reform; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 717Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; H.R. 3701 Family Vaccine Protection Act; H.R. 3521 Clinical Trial Modernization Act;;; HR 4417 Mobile Cancer Screening Act HR 3701 Family Vaccine Protection Act; HR 5304Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; S 2587 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; HR 5278/S 2756 Affordable Inhalers and Nebulizers Act of 2025; HR 6703 Lower Health Care Premiums for All Americans Act; S 2466 Senior Savings Protection Act; HR Senior Savings Protection Act; HR 6052 Elijah E. Cummings Family Asthma Act; HR 6319 Benay Taub Lung Cancer Research Act; HR 45448 Protecting Free Vaccines Act; Consolidated Appropriations Act, 2026; Breaking the Gridlock Act; HR 9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Issues relating to FY25 appropriations; Issues relating to the Presidents FY26 budget; Issues related to asthma, COPD, influenza, lung cancer, pneumonia, pulmonary fibrosis, tuberculosis and other lung diseases; Issues related to NIH reorganization; Issues related to agency restructuring; Issues related to lung disease treatment, prevention and research; Issues related to COVID-19; Issues related to telehealth; Issues related to infrastructure; Issues related to supplemental oxygen; Issues related to health equity; Issues related to Cancer Moonshot; Issues related to CDC public health workforce and data modernization; Issues related to regulatory reform; Issues related to Medicaid; H.R. 1509/S. 752, the Accelerating Kids Access to Care Act; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 717 Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; H.R. 3521 Clinical Trial Modernization Act; ;; HR 4417 Mobile Cancer Screening Act; HR 5304 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; S 2587 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; HR 5278/S 2756 Affordable Inhalers and Nebulizers Act of 2025; HR 45448 Protecting Free Vaccines Act; HR 9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to lung disease treatment, prevention and research; Issues related to public health; Issues related to tobacco cessation; Issues related to health inequities; Issues related to Medicaid waivers; Issues related to agency restructuring; Issues related to the Affordable Care Act; Issues related to supplemental oxygen; Issues related to access to healthcare; Issues related to COVID-19 Response; Issues related to Medicaid; Issues related to infrastructure; Issues related to health equity; Issues related to the implementation of the No Surprises Act; Issues related to Medicaid; Issues relating to the Presidents FY25 budget; Issues related to regulatory reform; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; S 717 Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; HR 6178 Increasing Access to Lung Cancer Screening Act; HR 6321 Lung Cancer Medicare Access to Precise Testing Act; HR 6320 Improving Medicaid Precision and Cancer Test Act of 2025; Consolidated Appropriations Act, 2026; HR 8839, Lanie Jones Comprehensive Cancer Survivorship Act of 2026; S. 4566, Increasing Access to Lung Cancer Screening Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"Issues related to tobacco use, lung cancer, lung disease treatment, prevention and research; and public health; Issues relating to the Presidents FY25 budget; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; Issues related to the Congressional Directed Medical Research Program;; HR 4016 Department of Defense Appropriations Act, 2026; S 2572 Department of Defense Appropriations Act, 2026; HR 9495, Department of Defense Appropriations Act, 2027","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TOB","general_issue_code_display":"Tobacco","description":"Issues related to lung disease treatment, prevention and research; Issues related to tobacco cessation; Issues related to agency restructuring; Issues related to smokefree air; Issues related to the Tobacco Control Act; Issues related to tobacco smuggling; Issues related to the Affordable Care Act; Issues related to menthol cigarettes; Issues related to tobacco prevention; Issues related to youth cessation research; Issues related to nicotine; Issues related to health equity; Issues related to COVID-19 Response; Issues related to tobacco litter; Issues related to synthetic nicotine; Issues related to regulatory reform; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; S. 2171 A bill to amend title 38, united States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes; H.R. 4121 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026; S 2256 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026; HR 6844 The Tobacco Tracking, Reporting, and Accountability for Compliance in Enforcement Act; HR 6845 Strengthening Task Force Operations to Prevent Illicit Vaping Act; S 3569 Strengthening Task Force Operations to Prevent Illicit Vaping Act; HR 8646, Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027; S 4257, Resources to Prevent Youth Vaping Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Issues related to taxes on tobacco products; Issues related to the Affordable Care Act; Issues related to COVID-19; Issues related to infrastructure; Issues relating to the Presidents FY25 budget; Issues relating to FY26 appropriations; S 317 Charitable Act; HR 801 Charitable Act; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":150198,"prefix":"mrs","prefix_display":"MRS.","first_name":"ELIZABETH","nickname":null,"middle_name":"ANNE MUELLER","last_name":"SCOTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"Issues related to lung disease treatment, prevention and research; Issues related to burn pits; Issues related to tobacco cessation; Issues related to smokefree air; Issues related to COVID-19 Response; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S. 2171 A bill to amend title 38, united States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/74afe73d-820d-4248-9b17-b7c149904c26/","filing_uuid":"74afe73d-820d-4248-9b17-b7c149904c26","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/74afe73d-820d-4248-9b17-b7c149904c26/print/","filing_document_content_type":"text/html","income":null,"expenses":"410000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Julie Stitzel","dt_posted":"2026-07-20T14:37:46-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"290 Harbor Drive","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Stamford","registrant_state":"CT","registrant_zip":"06902","registrant":{"id":401106760,"url":"https://lda.gov/api/v1/registrants/401106760/","house_registrant_id":45712,"name":"DIGITAL CURRENCY GROUP","description":null,"address_1":"262 Harbor Dr","address_2":null,"address_3":null,"address_4":null,"city":"Stamford","state":"CT","state_display":"Connecticut","zip":"06902","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JULIE STITZEL","contact_telephone":"+1 202-386-1259","dt_updated":"2026-07-20T14:39:02.223768-04:00"},"client":{"id":52614,"url":"https://lda.gov/api/v1/clients/52614/","client_id":52614,"name":"DIGITAL CURRENCY GROUP","general_description":"Support bitcoin & blockchain companies by leveraging insights, network & access to capital","client_government_entity":null,"client_self_select":true,"state":"CT","state_display":"Connecticut","country":"US","country_display":"United States of America","ppb_state":"CT","ppb_state_display":"Connecticut","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2022-07-01"},"lobbying_activities":[{"general_issue_code":"BAN","general_issue_code_display":"Banking","description":"General education around digital assets and decentralized AI S.875, FIRM Act S. 401, H.R. 987 Fair Access to Banking Act Legislation related to digital asset market structure legislation - HR 3633 (CLARITY Act) and the Responsible Financial Innovation Act of 2025. HR 1 (One Big Beautiful Bill Act) Issues related to the tax treatment of digital assets H.R.8149 - To amend the Internal Revenue Code of 1986 to clarify the tax treatment of digital asset rewards.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":139992,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"STITZEL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149565,"prefix":null,"prefix_display":null,"first_name":"TIFFANY","nickname":null,"middle_name":null,"last_name":"ANGULO","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"FIN","general_issue_code_display":"Financial Institutions/Investments/Securities","description":"General education around digital assets and decentralized AI To require the Secretary of the Treasury to develop a public-private partnership program with decentralized protocol developers and specialized auditing firms to examine embedded supervision and regulation of decentralized protocols, and for other purposes. H.R. 148, Keep Your Coins Act of 2025 S. 919, GENIUS Act H.R. 2392, STABLE Act H.R. 2384, Financial Technology Protection Act H.R.216, Securities Enforcement Clarity Act of 2025 H.R. 2365, Securities Clarity Act H.R.2032, BITCOIN Act H.Res.248, Resolution emphasizing the importance and power of distributed ledger technologies (DLT) to support democratic governance, human rights, internet freedom, and transparency. H.R. 1919, Anti-CBDC Surveillance State Act Legislation related to digital asset market structure legislation - HR 3633 (CLARITY Act) and the Responsible Financial Innovation Act of 2025. HR 1 (One Big Beautiful Bill Act) Issues related to the tax treatment of digital assets H.R.8149 - To amend the Internal Revenue Code of 1986 to clarify the tax treatment of digital asset rewards.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":139992,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"STITZEL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149565,"prefix":null,"prefix_display":null,"first_name":"TIFFANY","nickname":null,"middle_name":null,"last_name":"ANGULO","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"General education around digital assets and decentralized AI S.J. Res. 3, H.J. Res. 25 Resolution Disapproving Broker Rule Reconciliation/tax bill Legislation related to digital asset market structure legislation - HR 3633 (CLARITY Act) and the Responsible Financial Innovation Act of 2025. HR 1 (One Big Beautiful Bill Act) Issues related to the tax treatment of digital assets H.R.8149 - To amend the Internal Revenue Code of 1986 to clarify the tax treatment of digital asset rewards.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":139992,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"STITZEL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149565,"prefix":null,"prefix_display":null,"first_name":"TIFFANY","nickname":null,"middle_name":null,"last_name":"ANGULO","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"ENG","general_issue_code_display":"Energy/Nuclear","description":"General education around digital assets and decentralized AI Legislation related to digital asset market structure legislation - HR 3633 (CLARITY Act) and the Responsible Financial Innovation Act of 2025. HR 1 (One Big Beautiful Bill Act) Issues related to the tax treatment of digital assets H.R.8149 - To amend the Internal Revenue Code of 1986 to clarify the tax treatment of digital asset rewards.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":139992,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"STITZEL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149565,"prefix":null,"prefix_display":null,"first_name":"TIFFANY","nickname":null,"middle_name":null,"last_name":"ANGULO","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/b5e8f247-4858-4b04-9913-e5e670dcf9a3/","filing_uuid":"b5e8f247-4858-4b04-9913-e5e670dcf9a3","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/b5e8f247-4858-4b04-9913-e5e670dcf9a3/print/","filing_document_content_type":"text/html","income":null,"expenses":"680000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Cathleen Gates","dt_posted":"2026-07-20T15:11:41-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"2400 N Street, NW","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20037","registrant":{"id":1945,"url":"https://lda.gov/api/v1/registrants/1945/","house_registrant_id":30532,"name":"AMERICAN COLLEGE OF CARDIOLOGY","description":null,"address_1":"2400 N Street, NW","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20037","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"LUCAS SANDERS","contact_telephone":"+1 202-375-6397","dt_updated":"2026-07-29T12:01:27.325680-04:00"},"client":{"id":102667,"url":"https://lda.gov/api/v1/clients/102667/","client_id":12,"name":"AMERICAN COLLEGE OF CARDIOLOGY","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-09-28"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Health care quality; physician and hospital quality; health care innovation; Patient Protection and Affordable Care Act/health care reform implementation; unique device identifier policy and post-market surveillance for medical devices; clinical trial design; HIPAA and registries; federal funding/appropriations for HHS, NIH, AHRQ, CDC, FDA, HRSA and the Childrens Hospital Graduate Medical Education payment program, the Prevention & Public Health Fund, medical research, and prevention; research and scholarly communication policy; implementation and oversight of 21st Century Cures Act; data blocking/interoperability of electronic data; artificial intelligence/machine learning; algorithm transparency; health disparities; reduction/oversight of prior authorization and other administrative burdens; digital health; Sect. 1557 Nondiscrimination in Health Programs and Activities; cardiomyopathy education and awareness; peripheral arterial disease (PAD) education and awareness; VA Mission Act implementation; COVID-19 and implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act, the Families First Coronavirus Response Act , the Coronavirus Aid, Relief, and Economic Security Act, Coronavirus Provider Protection Act, and clinician mental health and wellbeing; patient identification; Pandemic and All Hazards Preparedness; MCIT/TCET/Breakthrough devices; Amputation Reduction and Compassion (ARC) Act (H.R. 307); Resident Education Deferred Interest (REDI) Act (H.R. 2028/S. 942); Implementation and funding for the Cardiomyopathy Health, Education, Awareness, Research and Training in Schools (HEARTS) Act (P.L. 118-176); provide AEDs in transportation facilities with the Public Access to Defibrillation in Transportation Facilities Act (H.R. 5897); Lorna Breen Health Care Provider Protection Reauthorization Act (H.R. 929/S. 266; Physician Led and Rural Access to Access to Quality Care Act (H.R. 2191/S. 1390); Section 232, National Security Investigation of Imports of Pharmaceuticals and Pharmaceutical Ingredients; and to protect health care workers from violence with the Save Healthcare Workers Act (H.R. 3178/S. 1600), Front of Package Food Labeling, The Medically Tailored Home-Delivered Meals Program Pilot Act (H.R. 5439/S. 2834); The Nursing is a Professional Degree Act (H.R. 8691/S. 4568), H.R.9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; and the H-1Bs for Physicians and the Healthcare Workforce Act (H.R. 7961).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":139239,"prefix":"mr","prefix_display":"MR.","first_name":"NOIA","nickname":null,"middle_name":"NICHOLAS","last_name":"MORSE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":54728,"prefix":"mr","prefix_display":"MR.","first_name":"LUCAS","nickname":null,"middle_name":"ROBERT","last_name":"SANDERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70525,"prefix":null,"prefix_display":null,"first_name":"JOHNATHON","nickname":null,"middle_name":null,"last_name":"KRISTAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":54536,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"VAVRICEK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139515,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"MINNELLA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148563,"prefix":"ms","prefix_display":"MS.","first_name":"AMANDA","nickname":null,"middle_name":null,"last_name":"CAVALLO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143678,"prefix":"mr","prefix_display":"MR.","first_name":"FOSTER","nickname":null,"middle_name":"PATRICK","last_name":"CURRY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147772,"prefix":null,"prefix_display":null,"first_name":"ADRIENNE","nickname":null,"middle_name":null,"last_name":"MORTIMER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153653,"prefix":null,"prefix_display":null,"first_name":"FAIZAH","nickname":null,"middle_name":null,"last_name":"PIRZADA","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":132,"name":"Agency for Healthcare Research & Quality (AHRQ)"},{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"The One Big Beautiful Bill Act, H.R. 1; Medicare physician payment including, the Medicare Patient Access and Practice Stabilization Act (H.R. 879); the Strengthening Medicare for Patients and Providers Act (H.R. 6160), the Provider Reimbursement Stability Act (S. 4935); the Provider Reimbursement Stability Act (H.R. 8163); and the Efficiency Adjustment Delay Act (H.R. 7520); new/alternative payment models; Medicare coverage, hospital payment of cardiovascular services; access to Medicare claims data; physician and hospital quality; Quality Payment Program; clinical data registries; health care quality; medical imaging and prior authorization; the Stark Law and the in-office ancillary services exception; Medicare Access and CHIP Reauthorization Act implementation and oversight; Bipartisan Budget Act of 2015 and Medicare site of service policy; graduate medical education policy including the Resident Physician Shortage Reduction Act (H.R. 3890/S. 2439); provide a specialty physician loan repayment program with the SPARC Act (H.R 4681/S. 1380); provide deferred interest payments for residents on student loans with the Resident Education Deferred Interest (REDI) Act (H.R. 2028/S. 942); oversight and implementation of the Protecting Access to Medicare Act of 2014, including Appropriate Use Criteria; physician-owned hospital policy including the Physician Led Rural Access to Quality Care Act (H.R. 2191/S. 1390) and the Patient Access to Higher Quality Health Care Act (H.R. 4002); COVID-19 public health emergency and the implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act, the Families First Coronavirus Response Act, the Coronavirus Aid, Relief, and Economic Security Act; implementation of the Protecting Medicare and American Farmers from Sequester Cuts Act; Increasing Access to Quality Cardiac Rehabilitation Care Act; the expansion of telehealth services, including the CONNECT for Health Act (H.R. 41894206/S. 1261), the Sustainable Cardiopulmonary Rehabilitation Services in the Home At (H.R. 783/S. 248), and the Telehealth Modernization Act (H.R. 5081/S. 2709); Improving maternal health, including Connected Maternal Online Monitoring Act (Connected MOM Act) (H.R. 4977/S. 141), Preventing Maternal Deaths Reauthorization Act of 2025 (H.R. 1909), and Rural Obstetrics Readiness Act (H.R. 1254/S. 380), and the Womens Heart Health Expansion Act (H.R. 7417/S. 3944) ; prior authorization reform, including the Improving Seniors Timely Access to Care Act (H.R. 3514/S. 1816), the Reducing Medically Unnecessary Delays in Care Act (H.R. 2433), and the Safe Step Act (H.R. 5509/S. 2903); clinician-led registry access to federal claims data, including the Access to Claims Data Act (H.R. 4331); and expanding in home prescribing coverage provided in the Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025 (H.R. 6894/S. 717), Centers for Medicare and Medicaid Innovation payment models.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":139239,"prefix":"mr","prefix_display":"MR.","first_name":"NOIA","nickname":null,"middle_name":"NICHOLAS","last_name":"MORSE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":54728,"prefix":"mr","prefix_display":"MR.","first_name":"LUCAS","nickname":null,"middle_name":"ROBERT","last_name":"SANDERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":54536,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"VAVRICEK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148568,"prefix":"ms","prefix_display":"MS.","first_name":"DEBRA","nickname":null,"middle_name":null,"last_name":"MARIANI-WEISSENBORN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70525,"prefix":null,"prefix_display":null,"first_name":"JOHNATHON","nickname":null,"middle_name":null,"last_name":"KRISTAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139515,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"MINNELLA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148563,"prefix":"ms","prefix_display":"MS.","first_name":"AMANDA","nickname":null,"middle_name":null,"last_name":"CAVALLO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143678,"prefix":"mr","prefix_display":"MR.","first_name":"FOSTER","nickname":null,"middle_name":"PATRICK","last_name":"CURRY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147772,"prefix":null,"prefix_display":null,"first_name":"ADRIENNE","nickname":null,"middle_name":null,"last_name":"MORTIMER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153653,"prefix":null,"prefix_display":null,"first_name":"FAIZAH","nickname":null,"middle_name":null,"last_name":"PIRZADA","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":253,"name":"Medicare Payment Advisory Commission (MedPAC)"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TOB","general_issue_code_display":"Tobacco","description":"Tobacco use prevention and smoking cessation; FDA regulation of tobacco; electronic cigarettes and nicotine products; tobacco and electronic cigarette policy in House and Senate Appropriations; Federal funding for the CDCs Office of Smoking and Health and chronic disease prevention.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":139239,"prefix":"mr","prefix_display":"MR.","first_name":"NOIA","nickname":null,"middle_name":"NICHOLAS","last_name":"MORSE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":54728,"prefix":"mr","prefix_display":"MR.","first_name":"LUCAS","nickname":null,"middle_name":"ROBERT","last_name":"SANDERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70525,"prefix":null,"prefix_display":null,"first_name":"JOHNATHON","nickname":null,"middle_name":null,"last_name":"KRISTAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":54536,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"VAVRICEK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148563,"prefix":"ms","prefix_display":"MS.","first_name":"AMANDA","nickname":null,"middle_name":null,"last_name":"CAVALLO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143678,"prefix":"mr","prefix_display":"MR.","first_name":"FOSTER","nickname":null,"middle_name":"PATRICK","last_name":"CURRY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147772,"prefix":null,"prefix_display":null,"first_name":"ADRIENNE","nickname":null,"middle_name":null,"last_name":"MORTIMER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153653,"prefix":null,"prefix_display":null,"first_name":"FAIZAH","nickname":null,"middle_name":null,"last_name":"PIRZADA","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/3ee0a6e3-cfc1-45d0-9e4f-2886ce95650b/","filing_uuid":"3ee0a6e3-cfc1-45d0-9e4f-2886ce95650b","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/3ee0a6e3-cfc1-45d0-9e4f-2886ce95650b/print/","filing_document_content_type":"text/html","income":"20000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Matt McGinley","dt_posted":"2026-10-13T11:14:51-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"2503-D Harrison Street North #1210","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Arlington","registrant_state":"VA","registrant_zip":"22207","registrant":{"id":401103524,"url":"https://lda.gov/api/v1/registrants/401103524/","house_registrant_id":null,"name":"ADVANCED POLICY CONSULTING, LLC","description":"Consulting","address_1":"2503-D Harrison Street North #1210","address_2":null,"address_3":null,"address_4":null,"city":"Arlington","state":"VA","state_display":"Virginia","zip":"22207","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MATT MCGINLEY","contact_telephone":"+1 703-536-1705","dt_updated":"2026-07-24T11:29:57.639066-04:00"},"client":{"id":53847,"url":"https://lda.gov/api/v1/clients/53847/","client_id":53847,"name":"ATA ACTION","general_description":"Trade organization advocating for telehealth","client_government_entity":null,"client_self_select":false,"state":"VA","state_display":"Virginia","country":"US","country_display":"United States of America","ppb_state":"VA","ppb_state_display":"Virginia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2023-01-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Telehealth Expansion Act (H.R. 1650 / S. 763) Permanent Telehealth from Home Act (H.R. 1407) Audio-Only Telehealth Services Act (H.R. 1899) Expanded Provider Access Act (H.R. 1614) TREATS Act (H.R. 1627) PREVENT DIABETES Act (H.R. 1523) Sustainable Cardiopulmonary Rehabilitation in the Home Act (H.R. 783 / S. 248) Hospice Recertification Flexibility Act (H.R. 1720) Rural Telehealth and Education Enhancement Act (H.R. 290) Monitor Prescription Digital Therapeutics policy. H.R.6994 - To amend the Controlled Substances Act to modify requirements relating to the prescription of controlled substances by means of the Internet, and for other purposes. Education regarding DEA's final telemedicine rule.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":62356,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"MCGINLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":198,"name":"Natl Economic Council (NEC)"},{"id":19,"name":"Office of Natl Drug Control Policy (NDCP)"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"CONNECT for Health Act Reintroduction Telehealth Modernization Act Reintroduction Promote medicare Telehealth extension in government funding legislation.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":62356,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"MCGINLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":198,"name":"Natl Economic Council (NEC)"},{"id":19,"name":"Office of Natl Drug Control Policy (NDCP)"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/13b083b5-68e9-443f-9c50-76b4f16fdb5a/","filing_uuid":"13b083b5-68e9-443f-9c50-76b4f16fdb5a","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/13b083b5-68e9-443f-9c50-76b4f16fdb5a/print/","filing_document_content_type":"text/html","income":null,"expenses":"600000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Cathleen Gates","dt_posted":"2026-10-14T08:26:30-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"2400 N Street, NW","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20037","registrant":{"id":1945,"url":"https://lda.gov/api/v1/registrants/1945/","house_registrant_id":30532,"name":"AMERICAN COLLEGE OF CARDIOLOGY","description":null,"address_1":"2400 N Street, NW","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20037","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"LUCAS SANDERS","contact_telephone":"+1 202-375-6397","dt_updated":"2026-07-29T12:01:27.325680-04:00"},"client":{"id":102667,"url":"https://lda.gov/api/v1/clients/102667/","client_id":12,"name":"AMERICAN COLLEGE OF CARDIOLOGY","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-09-28"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Health care quality; physician and hospital quality; health care innovation; Patient Protection and Affordable Care Act/health care reform implementation; unique device identifier policy and post-market surveillance for medical devices; clinical trial design; HIPAA and registries; federal funding/appropriations for HHS, NIH, AHRQ, CDC, FDA, HRSA and the Childrens Hospital Graduate Medical Education payment program, the Prevention & Public Health Fund, medical research, and prevention; research and scholarly communication policy; implementation and oversight of 21st Century Cures Act; data blocking/interoperability of electronic data; artificial intelligence/machine learning; algorithm transparency; health disparities; reduction/oversight of prior authorization and other administrative burdens; digital health; Sect. 1557 Nondiscrimination in Health Programs and Activities; cardiomyopathy education and awareness; peripheral arterial disease (PAD) education and awareness; VA Mission Act implementation; COVID-19 and implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act, the Families First Coronavirus Response Act , the Coronavirus Aid, Relief, and Economic Security Act, Coronavirus Provider Protection Act, and clinician mental health and wellbeing; patient identification; Pandemic and All Hazards Preparedness; RAPID coverage program and Breakthrough Device policy; Amputation Reduction and Compassion (ARC) Act (H.R. 307); Resident Education Deferred Interest (REDI) Act (H.R. 2028/S. 942); Implementation and funding for the Cardiomyopathy Health, Education, Awareness, Research and Training in Schools (HEARTS) Act (P.L. 118-176); provide AEDs in transportation facilities with the Public Access to Defibrillation in Transportation Facilities Act (H.R. 5897); Residential AED and CPR Preparedness Act of 2026 (H.R. 9058); Lorna Breen Health Care Provider Protection Reauthorization Act (H.R. 929/S. 266; Physician Led and Rural Access to Access to Quality Care Act (H.R. 2191/S. 1390); Section 232, National Security Investigation of Imports of Pharmaceuticals and Pharmaceutical Ingredients; and to protect health care workers from violence with the Save Healthcare Workers Act (H.R. 3178/S. 1600), Front of Package Food Labeling, The Medically Tailored Home-Delivered Meals Program Pilot Act (H.R. 5439/S. 2834); The Nursing is a Professional Degree Act (H.R. 8691/S. 4568), H.R.9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; and the H-1Bs for Physicians and the Healthcare Workforce Act (H.R. 7961); Protecting Patients from Automated Denials Act (H.R. 9734); and the Doctors Not AI Act (H.R. 101210).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":139239,"prefix":"mr","prefix_display":"MR.","first_name":"NOIA","nickname":null,"middle_name":"NICHOLAS","last_name":"MORSE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":54728,"prefix":"mr","prefix_display":"MR.","first_name":"LUCAS","nickname":null,"middle_name":"ROBERT","last_name":"SANDERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70525,"prefix":null,"prefix_display":null,"first_name":"JOHNATHON","nickname":null,"middle_name":null,"last_name":"KRISTAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":54536,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"VAVRICEK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139515,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"MINNELLA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148563,"prefix":"ms","prefix_display":"MS.","first_name":"AMANDA","nickname":null,"middle_name":null,"last_name":"CAVALLO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143678,"prefix":"mr","prefix_display":"MR.","first_name":"FOSTER","nickname":null,"middle_name":"PATRICK","last_name":"CURRY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147772,"prefix":null,"prefix_display":null,"first_name":"ADRIENNE","nickname":null,"middle_name":null,"last_name":"MORTIMER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153653,"prefix":null,"prefix_display":null,"first_name":"FAIZAH","nickname":null,"middle_name":null,"last_name":"PIRZADA","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":132,"name":"Agency for Healthcare Research & Quality (AHRQ)"},{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"The One Big Beautiful Bill Act, H.R. 1; Medicare physician payment including, the Medicare Patient Access and Practice Stabilization Act (H.R. 879); the Strengthening Medicare for Patients and Providers Act (H.R. 6160), the Provider Reimbursement Stability Act (S. 4935); the Provider Reimbursement Stability Act (H.R. 8163/S. 5180); and the Efficiency Adjustment Delay Act (H.R. 7520); new/alternative payment models; Medicare coverage, hospital payment of cardiovascular services; access to Medicare claims data; physician and hospital quality; Quality Payment Program; clinical data registries; health care quality; medical imaging and prior authorization; the Stark Law and the in-office ancillary services exception; Medicare Access and CHIP Reauthorization Act implementation and oversight; Bipartisan Budget Act of 2015 and Medicare site of service policy; graduate medical education policy including the Resident Physician Shortage Reduction Act (H.R. 3890/S. 2439); provide a specialty physician loan repayment program with the SPARC Act (H.R 4681/S. 1380); provide deferred interest payments for residents on student loans with the Resident Education Deferred Interest (REDI) Act (H.R. 2028/S. 942); oversight and implementation of the Protecting Access to Medicare Act of 2014, including Appropriate Use Criteria; physician-owned hospital policy including the Physician Led Rural Access to Quality Care Act (H.R. 2191/S. 1390) and the Patient Access to Higher Quality Health Care Act (H.R. 4002); COVID-19 public health emergency and the implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act, the Families First Coronavirus Response Act, the Coronavirus Aid, Relief, and Economic Security Act; implementation of the Protecting Medicare and American Farmers from Sequester Cuts Act; Increasing Access to Quality Cardiac Rehabilitation Care Act; the expansion of telehealth services, including the CONNECT for Health Act (H.R. 41894206/S. 1261), the Sustainable Cardiopulmonary Rehabilitation Services in the Home At (H.R. 783/S. 248), and the Telehealth Modernization Act (H.R. 5081/S. 2709); Improving maternal health, including Connected Maternal Online Monitoring Act (Connected MOM Act) (H.R. 4977/S. 141), Preventing Maternal Deaths Reauthorization Act of 2025 (H.R. 1909), and Rural Obstetrics Readiness Act (H.R. 1254/S. 380), and the Womens Heart Health Expansion Act (H.R. 7417/S. 3944) ; prior authorization reform, including the Improving Seniors Timely Access to Care Act (H.R. 3514/S. 1816), the Reducing Medically Unnecessary Delays in Care Act (H.R. 2433), and the Safe Step Act (H.R. 5509/S. 2903); clinician-led registry access to federal claims data, including the Access to Claims Data Act (H.R. 4331); and expanding in home prescribing coverage provided in the Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025 (H.R. 6894/S. 717), Centers for Medicare and Medicaid Innovation payment models, including the Ambulatory Specialty Model for Heart Failure.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":139239,"prefix":"mr","prefix_display":"MR.","first_name":"NOIA","nickname":null,"middle_name":"NICHOLAS","last_name":"MORSE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":54728,"prefix":"mr","prefix_display":"MR.","first_name":"LUCAS","nickname":null,"middle_name":"ROBERT","last_name":"SANDERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":54536,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"VAVRICEK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148568,"prefix":"ms","prefix_display":"MS.","first_name":"DEBRA","nickname":null,"middle_name":null,"last_name":"MARIANI-WEISSENBORN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70525,"prefix":null,"prefix_display":null,"first_name":"JOHNATHON","nickname":null,"middle_name":null,"last_name":"KRISTAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139515,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"MINNELLA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148563,"prefix":"ms","prefix_display":"MS.","first_name":"AMANDA","nickname":null,"middle_name":null,"last_name":"CAVALLO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143678,"prefix":"mr","prefix_display":"MR.","first_name":"FOSTER","nickname":null,"middle_name":"PATRICK","last_name":"CURRY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147772,"prefix":null,"prefix_display":null,"first_name":"ADRIENNE","nickname":null,"middle_name":null,"last_name":"MORTIMER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153653,"prefix":null,"prefix_display":null,"first_name":"FAIZAH","nickname":null,"middle_name":null,"last_name":"PIRZADA","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":253,"name":"Medicare Payment Advisory Commission (MedPAC)"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TOB","general_issue_code_display":"Tobacco","description":"Tobacco use prevention and smoking cessation; FDA regulation of tobacco; electronic cigarettes and nicotine products; tobacco and electronic cigarette policy in House and Senate Appropriations; Federal funding for the CDCs Office of Smoking and Health and chronic disease prevention.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":139239,"prefix":"mr","prefix_display":"MR.","first_name":"NOIA","nickname":null,"middle_name":"NICHOLAS","last_name":"MORSE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":54728,"prefix":"mr","prefix_display":"MR.","first_name":"LUCAS","nickname":null,"middle_name":"ROBERT","last_name":"SANDERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70525,"prefix":null,"prefix_display":null,"first_name":"JOHNATHON","nickname":null,"middle_name":null,"last_name":"KRISTAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":54536,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"VAVRICEK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148563,"prefix":"ms","prefix_display":"MS.","first_name":"AMANDA","nickname":null,"middle_name":null,"last_name":"CAVALLO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143678,"prefix":"mr","prefix_display":"MR.","first_name":"FOSTER","nickname":null,"middle_name":"PATRICK","last_name":"CURRY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147772,"prefix":null,"prefix_display":null,"first_name":"ADRIENNE","nickname":null,"middle_name":null,"last_name":"MORTIMER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153653,"prefix":null,"prefix_display":null,"first_name":"FAIZAH","nickname":null,"middle_name":null,"last_name":"PIRZADA","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/c37420cf-33fd-4e54-915c-d59c9f4f5921/","filing_uuid":"c37420cf-33fd-4e54-915c-d59c9f4f5921","filing_type":"3A","filing_type_display":"3rd Quarter - Amendment","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/c37420cf-33fd-4e54-915c-d59c9f4f5921/print/","filing_document_content_type":"text/html","income":"20000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Matt McGinley","dt_posted":"2026-10-14T18:50:05-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"2503-D Harrison Street North #1210","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Arlington","registrant_state":"VA","registrant_zip":"22207","registrant":{"id":401103524,"url":"https://lda.gov/api/v1/registrants/401103524/","house_registrant_id":null,"name":"ADVANCED POLICY CONSULTING, LLC","description":"Consulting","address_1":"2503-D Harrison Street North #1210","address_2":null,"address_3":null,"address_4":null,"city":"Arlington","state":"VA","state_display":"Virginia","zip":"22207","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MATT MCGINLEY","contact_telephone":"+1 703-536-1705","dt_updated":"2026-07-24T11:29:57.639066-04:00"},"client":{"id":53847,"url":"https://lda.gov/api/v1/clients/53847/","client_id":53847,"name":"ATA ACTION","general_description":"Trade organization advocating for telehealth","client_government_entity":null,"client_self_select":false,"state":"VA","state_display":"Virginia","country":"US","country_display":"United States of America","ppb_state":"VA","ppb_state_display":"Virginia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2023-01-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Telehealth Expansion Act (H.R. 1650 / S. 763) Permanent Telehealth from Home Act (H.R. 1407) Audio-Only Telehealth Services Act (H.R. 1899) Expanded Provider Access Act (H.R. 1614) TREATS Act (H.R. 1627) PREVENT DIABETES Act (H.R. 1523) Sustainable Cardiopulmonary Rehabilitation in the Home Act (H.R. 783 / S. 248) Hospice Recertification Flexibility Act (H.R. 1720) Rural Telehealth and Education Enhancement Act (H.R. 290) Monitor Prescription Digital Therapeutics policy. H.R.6994 - To amend the Controlled Substances Act to modify requirements relating to the prescription of controlled substances by means of the Internet, and for other purposes. Education regarding DEA's final telemedicine rule. Education about asynchronous telemedicine and letters of medical necessity in the FSA/HSA space.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":62356,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"MCGINLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":188,"name":"Internal Revenue Service (IRS)"},{"id":198,"name":"Natl Economic Council (NEC)"},{"id":19,"name":"Office of Natl Drug Control Policy (NDCP)"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"CONNECT for Health Act Reintroduction Telehealth Modernization Act Reintroduction Promote medicare Telehealth extension in government funding legislation.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":62356,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"MCGINLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":198,"name":"Natl Economic Council (NEC)"},{"id":19,"name":"Office of Natl Drug Control Policy (NDCP)"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/a41d71e1-216c-44e8-91c3-2915ee8c3c21/","filing_uuid":"a41d71e1-216c-44e8-91c3-2915ee8c3c21","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/a41d71e1-216c-44e8-91c3-2915ee8c3c21/print/","filing_document_content_type":"text/html","income":null,"expenses":"86949.00","expenses_method":"B","expenses_method_display":"B","posted_by_name":"Kyle Zebley","dt_posted":"2026-10-20T09:55:23-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"601 13th St NW","registrant_address_2":"12th Floor","registrant_different_address":true,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":401106410,"url":"https://lda.gov/api/v1/registrants/401106410/","house_registrant_id":45477,"name":"ATA ACTION","description":null,"address_1":"601 13th St NW","address_2":"12th Floor","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"KYLE ZEBLEY","contact_telephone":"+1 412-760-8098","dt_updated":"2026-08-31T11:40:33.575220-04:00"},"client":{"id":50919,"url":"https://lda.gov/api/v1/clients/50919/","client_id":50919,"name":"ATA ACTION","general_description":"Trade organization advocating for telehealth","client_government_entity":null,"client_self_select":true,"state":"VA","state_display":"Virginia","country":"US","country_display":"United States of America","ppb_state":"VA","ppb_state_display":"Virginia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2022-01-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"ATA Action - Federal Legislative Priorities (119th Congress) As of Q4 2025, ATA Action continues to support and lobby for a broad portfolio of bipartisan legislation aimed at making telehealth and digital health a permanent, integrated part of care delivery in the U.S. healthcare system. Below is a summary of the legislation we are actively engaging on: 🔹 Top Legislative Priorities Telehealth Expansion Act (H.R. 1650 / S. 763) Sponsors: Rep. Arrington (R-TX), Rep. Susie Lee (D-NV), Sen. Daines (R-MT), Sen. Cortez Masto (D-NV) → Makes permanent the ability to offer pre-deductible telehealth services under high-deductible health plans linked to HSAs. Permanent Telehealth from Home Act (H.R. 1407) Sponsors: Rep. Buchanan (R-FL), Rep. Max Miller (R-OH), Rep. Mike Thompson (D-CA) → Eliminates originating site and geographic restrictions for Medicare telehealth services permanently. Audio-Only Telehealth Services Act (H.R. 1899) Sponsors: Rep. Feenstra (R-IA), Rep. Pappas (D-NH) → Makes permanent coverage of audio-only services in Medicare. Expanded Provider Access Act (H.R. 1614) Sponsors: Rep. Kelly (R-PA), Rep. Mike Thompson (D-CA) → Permits therapists, audiologists, and speech-language pathologists to deliver telehealth services permanently. TREATS Act (H.R. 1627) Sponsors: Rep. Norcross (D-NJ), Rep. Fitzpatrick (R-PA) → Permanently waives the in-person requirement for prescribing controlled substances (Schedules III-IV) via telehealth for substance use and opioid use disorders. 🔹 Additional Supported Legislation PREVENT DIABETES Act (H.R. 1523) Sponsors: Rep. DeGette (D-CO), Rep. Bilirakis (R-FL) → Expands Medicare Diabetes Prevention Program to include virtual suppliers. Sustainable Cardiopulmonary Rehabilitation in the Home Act (H.R. 783 / S. 248) Sponsors: Rep. Joyce (R-PA), Rep. Peters (D-CA), Sen. Blackburn (R-TN), Sen. Klobuchar (D-MN) → Makes permanent the option to provide cardiopulmonary rehab services at home via telehealth. Hospice Recertification Flexibility Act (H.R. 1720) Sponsors: Rep. Carol Miller (R-WV), Rep. Jared Golden (D-ME) → Allows hospice recertification visits via telehealth beyond 180 days. Rural Telehealth and Education Enhancement Act (H.R. 290) Sponsors: Rep. Langworthy (R-NY), Rep. Pingree (D-ME) → Reauthorizes USDAs Distance Learning and Telemedicine grant program through FY2030. ATA Action is actively advocating for these bills through direct engagement with congressional offices, testimony, coalition coordination, and public policy campaigns. This legislative portfolio reflects our commitment to securing permanent access to telehealth and integrating next-generation digital tools across care settings nationwide.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":139283,"prefix":"mr","prefix_display":"MR.","first_name":"KYLE","nickname":null,"middle_name":null,"last_name":"ZEBLEY","suffix":null,"suffix_display":null},"covered_position":"Legislative Director/Senior Legislative Assistant/Legislative Assistant, Rep. Tom Price (R-GA); Chief of Staff/Senior Advisor, HHS Office of the Secretary","new":false},{"lobbyist":{"id":154228,"prefix":null,"prefix_display":null,"first_name":"JOE","nickname":null,"middle_name":null,"last_name":"NYE","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"CONNECT for Health Act Reintroduction ATA Action strongly supports the Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act, the most comprehensive bipartisan telehealth legislation in Congress. The bill would permanently remove geographic and originating site restrictions, expand eligible providers, and allow patients to access care from their homes. It represents a critical step toward ensuring telehealth remains a foundational element of modern healthcare. Telehealth Modernization Act Reintroduction ATA Action endorses the Telehealth Modernization Act, which codifies the key Medicare telehealth flexibilities first introduced during the COVID-19 pandemic. The bill eliminates outdated site restrictions and empowers patients to receive care where and when they need it. This legislation is essential to maintaining progress and providing certainty to patients, providers, and health systems.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":139283,"prefix":"mr","prefix_display":"MR.","first_name":"KYLE","nickname":null,"middle_name":null,"last_name":"ZEBLEY","suffix":null,"suffix_display":null},"covered_position":"Legislative Director/Senior Legislative Assistant/Legislative Assistant, Rep. Tom Price (R-GA); Chief of Staff/Senior Advisor, HHS Office of the Secretary","new":false},{"lobbyist":{"id":138681,"prefix":null,"prefix_display":null,"first_name":"ALEXIS","nickname":null,"middle_name":"MARIA","last_name":"APPLE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/8aa76a1c-844e-4c06-ae85-982473e899d8/","filing_uuid":"8aa76a1c-844e-4c06-ae85-982473e899d8","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/8aa76a1c-844e-4c06-ae85-982473e899d8/print/","filing_document_content_type":"text/html","income":null,"expenses":"70000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Laura Katherine Bender","dt_posted":"2026-10-20T14:08:23-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"1331 Pennsylvania Ave NW","registrant_address_2":"Suite 1425 North","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":2811,"url":"https://lda.gov/api/v1/registrants/2811/","house_registrant_id":30549,"name":"AMERICAN LUNG ASSOCIATION","description":null,"address_1":"1331 Pennsylvania Ave NW","address_2":"Suite 1425 North","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"LAURA BENDER","contact_telephone":"+1 202-715-3457","dt_updated":"2026-07-20T09:13:00.293676-04:00"},"client":{"id":103597,"url":"https://lda.gov/api/v1/clients/103597/","client_id":12,"name":"AMERICAN LUNG ASSOCIATION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-02"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Issues related to lung disease treatment, prevention and research; public health; tobacco control and air pollution; Issues related to the Affordable Care Act; Issues related to COVID-19 Response; Issues related to infrastructure; Issues related to agency restructuring; Issues relating to FY26 appropriations; Issues relating to FY27 appropriations; S 317 Charitable Act; HR 801 Charitable Act; Consolidated Appropriations Act, 2026; Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026; Breaking the Gridlock Act; HR 9171, Department of Interior, Environment and Related Agencies Appropriations Act, 207; HR 9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; HR 8646, Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027; S 4257, Resources to Prevent Youth Vaping Act; HR 9495, Department of Defense Appropriations Act, 2027; HR 6500, Continuing Appropriations and Extensions Act, 2027","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150198,"prefix":"mrs","prefix_display":"MRS.","first_name":"ELIZABETH","nickname":null,"middle_name":"ANNE MUELLER","last_name":"SCOTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":49,"name":"Environmental Protection Agency (EPA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CAW","general_issue_code_display":"Clean Air and Water (quality)","description":"Issues related to the health impacts of air pollution and climate change; Issues related to air pollution from stationary and mobile sources; Issues related to the Clean Air Act; Issues related to California Clean Air Act waivers; Issues related to permitting and regulatory reforms; Issues related to infrastructure; Issues related to agency restructuring; Issues relating to FY26 appropriations; Issues relating to FY27 appropriations; Issues related to implementation of the Inflation Reduction Act; Issues related to appliance efficiency; issues related to prescribed burning; S1072 Stop California from Advancing Regulatory Burden Act; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; HR 471 Fix Our Forests; HJ Res 15/SJ Res 4 Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Energy relating to \"Energy Conservation Program: Energy Conservation Standards for Commercial Water Heating Equipment\"; HR 903/S 341 Smoke and Heat Ready Communities Act; HR 1449 Energy Resilient Communities Act; S 711 Transportation Freedom Act; HR 1651 To nullify the final rule issued by the Environmental Protection Agency relating to \"New Source Performance Standards for Greenhouse Gas Emissions From New, Modified, and Reconstructed Fossil Fuel-Fired Electric Generating Units; Emission Guidelines for Greenhouse Gas Emissions From Existing Fossil Fuel-Fired Electric Generating Units; and Repeal of the Affordable Clean Energy Rule\"; HR 1415/S 623 No Industrial Restrictions In Secret (No IRIS) Act; HR 2140 DERA Act 2025; S 1072 Stop CARB Act of 2025; HR 2165 Choice in Automobile Retail Sales (CARS) Act; HR 346 Preserving Choice in Vehicle Purchases Act; HR 2288 To nullify the final rule of the Environmental Protection Agency titled \"Reconsideration of the National Ambient Air Quality Standards for Particulate Matter\"; HR 3889/S 2015 National Prescribed Fire Act; H.Res. 585 Recognizing the threat of extreme weather to childrens health and wellbeing, and expressing the sense of Congress that solutions must be rapidly and equitably developed and deployed to address the unique vulnerabilities and needs of children; HR 4443/S 2298 Asuncion Valdivia Heat Illness, Injury, and Fatality Prevention Act; S 2340/HR 4515 Climate Change Health Protection and Promotion Act of 2025; HR 4744/S 2445 Community Mental Wellness and Resilience Act; HR 161 New Source Review Permitting Improvement Act; HR 6387 Fire Improvement and Reforming Exceptional Events Act; HR 6409 Foreign Emissions and Nonattainment Clarification for Economic Stability Act; HR 6398 Reducing and Eliminating Duplicative Environmental Regulations Act; HR 6373 Air Permitting Improvements to Protect National Security Act; H.R. 4214 Clean Air and Building Infrastructure Improvement Act; HR 4776 SPEED Act; S 3529 Public Health Air Quality Act; S 3007, Diesel Truck Liberation Act; S 237 Honoring Our Fallen Heroes Act; Commerce, Justice, Science; HR 5437 Protection of Lawful Commerce in Stone Slab Products Act; H.R. 4626 Home Appliance Protection and Affordability Act; H.R. 4758 Homeowner Energy Freedom Act; H.R. 7977 Energy Bills Relief Act; H.R. 7821 Promoting Reduction of Emissions through Landscaping Act; Discussion Draft of Legislation to Modernize the Toxic Substances Control Act ; H.R. 4593 SHOWER Act; H.R. 5184 Affordable HOMES Act; HR 4690, Reliable Federal Infrastructure Act; HR 3194, LOCOMOTIVES Act; HR 6200, ESSENTIAL Act; HR 6250, Cold Weather Diesel Reliability Act; HR 7000, Freedom to Fuel Act; HR 8782, PLOW Storms Act; HR 8870, Build America 250 Act; HR 9022, Fiscal Year 2027 Energy and Water Appropriations Bill; HR 9243/S 4732, Wildfire Smoke Emergency Declaration Act; HR 9453/S 4931, End EPA Abuse Act;HR 9171, Department of Interior, Environment and Related Agencies Appropriations Act, 2027; HR 9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; HR 9170, Transportation, Housing and Urban Development and Related Agencies Appropriations Act, 2027; HR 9317, Buses Utilizing Safety and Environmental Standards Act; HR 9618, Diesel Engine Flexibility Act; S 4404, No Passes for Polluters Act; S 5045, Wildfire Emissions Prevention Act; HR 9019, POWER Act; S 5092, Restoring Affordability in Automobile Manufacturing; S. 5311, Cabin Air Safety Act; S 5215, Cleaner Transportation Access for All; HR 10065, Methane Polluter Accountability Act; S5338, Energy Efficiency Reform Act; HR 10154, Protect America from CARB Act; HJ Res 202, Providing congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"California State Motor Vehicle Pollution Control Standards; Notice of Decision Granting a Waiver of Clean Air Act Preemption for California's 2009 and Subsequent Model Year Greenhouse Gas Emission Standards for New Motor Vehicles\"; HJ Res 211, Providing congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"California State Motor Vehicle Pollution Control Standards; Notice of Decision Granting a Waiver of Clean Air Act Preemption for California's 2009 and Subsequent Model Year Greenhouse Gas Emission Standards for New Motor Vehicles\"; SJ Res 206, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"California State Motor Vehicle Pollution Control Standards; Notice of Decision Granting a Waiver of Clean Air Act Preemption for California's 2009 and Subsequent Model Year Greenhouse Gas Emission Standards for New Motor Vehicles\"; SJ Res 207, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"California State Motor Vehicle Pollution Control Standards; Notice of Decision Granting a Waiver of Clean Air Act Preemption for California's Advanced Clean Car Program and a Within the Scope Conformation for California's Zero Emission Vehicle Amendments for 2017 and Earlier Model Years\"; HJ Res 212, Providing congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"California State Motor Vehicle Pollution Control Standards; Advanced Clean Car Program; Reconsideration of a Previous Withdrawal of a Waiver of Preemption; Notice of Decision\"; SJ Res 208, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"California State Motor Vehicle Pollution Control Standards; Advanced Clean Car Program; Reconsideration of a Previous Withdrawal of a Waiver of Preemption; Notice of Decision\"; HJ Res 214, Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"California State Nonroad Engine Pollution Control Standards; Small Off-Road Engines Regulations; Notice of Decision\"; SJ Res 205, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"California State Nonroad Engine Pollution Control Standards; Small Off-Road Engines Regulations; Notice of Decision; HJ Res 210, Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"California State Nonroad Engine Pollution Control Standards; Ocean-Going Vessels At-Berth; Notice of Decision\".; SJ Res 209, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"California State Nonroad Engine Pollution Control Standards; Ocean-Going Vessels At-Berth; Notice of Decision\"; HJ Res 213, Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule issued by the Environmental Protection Agency relating to the \"California State Nonroad Engine Pollution Control Standards; Commercial Harbor Craft Regulations; Notice of Decision\"; SJ Res 210, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating \"California State Nonroad Engine Pollution Control Standards; Commercial Harbor Craft Regulations; Notice of Decision\"; S. 5653, Bipartisan American Affordability and Jobs Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":150198,"prefix":"mrs","prefix_display":"MRS.","first_name":"ELIZABETH","nickname":null,"middle_name":"ANNE MUELLER","last_name":"SCOTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":33,"name":"Energy, Dept of"},{"id":49,"name":"Environmental Protection Agency (EPA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":36,"name":"Interior, Dept of (DOI)"},{"id":188,"name":"Internal Revenue Service (IRS)"},{"id":175,"name":"Natl Highway Traffic Safety Administration (NHTSA)"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"},{"id":40,"name":"Transportation, Dept of (DOT)"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to lung disease treatment, prevention and research; Issues related to public health; Issues related asthma, COPD, influenza, lung cancer, pneumonia, pulmonary fibrosis, tuberculosis and other lung diseases; Issues related to tobacco cessation; Issues related to the Affordable Care Act; Issues related to agency restructuring; Issues related to the Childrens Health Insurance Program; Issues related to Medicaid; Issues related to ERISA; Issues related to COVID-19 Response; Issues related to vaccines; Issues related to infrastructure; Issues related to supplemental oxygen; Issues related to the implementation of the No Surprises Act; Issues related to Medicare sequestration; Issues related to Cancer Moonshot; Issues related to short-term limited duration plans; Issues related to Healthy Future Taskforce; Issues related to regulatory reform; Issues relating to FY26 appropriations; Issues relating to FY27 appropriations; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 717Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; H.R. 3701 Family Vaccine Protection Act; H.R. 3521 Clinical Trial Modernization Act; HR 4417 Mobile Cancer Screening Act HR 3701 Family Vaccine Protection Act; HR 5304Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; S 2587 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; HR 5278/S 2756 Affordable Inhalers and Nebulizers Act of 2025; HR 6703 Lower Health Care Premiums for All Americans Act; S 2466 Senior Savings Protection Act; HR Senior Savings Protection Act; HR 6052 Elijah E. Cummings Family Asthma Act; HR 6319 Benay Taub Lung Cancer Research Act; HR 45448 Protecting Free Vaccines Act; Consolidated Appropriations Act, 2026; Breaking the Gridlock Act; HR 9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; S. 4440, Clinical Trial Modernization Act; S. 5428, Stop the Wait Act of 2026; H.R. 2319, Women and Lung Cancer Research and Preventive Services Act of 2025; S. 1157 Women and Lung Cancer Research and Preventive Services Act of 2025","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Issues relating to FY25 appropriations; Issues relating to the Presidents FY26 budget; Issues related to asthma, COPD, influenza, lung cancer, pneumonia, pulmonary fibrosis, tuberculosis and other lung diseases; Issues related to NIH reorganization; Issues related to agency restructuring; Issues related to lung disease treatment, prevention and research; Issues related to COVID-19; Issues related to telehealth; Issues related to infrastructure; Issues related to supplemental oxygen; Issues related to health equity; Issues related to Cancer Moonshot; Issues related to CDC public health workforce and data modernization; Issues related to regulatory reform; Issues related to Medicaid; H.R. 1509/S. 752, the Accelerating Kids Access to Care Act; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 717 Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; H.R. 3521 Clinical Trial Modernization Act; HR 4417 Mobile Cancer Screening Act; HR 5304 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; S 2587 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; HR 5278/S 2756 Affordable Inhalers and Nebulizers Act of 2025; HR 45448 Protecting Free Vaccines Act; HR 9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; S. 4440, Clinical Trial Modernization Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to lung disease treatment, prevention and research; Issues related to public health; Issues related to tobacco cessation; Issues related to health inequities; Issues related to Medicaid waivers; Issues related to agency restructuring; Issues related to the Affordable Care Act; Issues related to supplemental oxygen; Issues related to access to healthcare; Issues related to COVID-19 Response; Issues related to Medicaid; Issues related to infrastructure; Issues related to health equity; Issues related to the implementation of the No Surprises Act; Issues related to Medicaid; Issues relating to the Presidents FY25 budget; Issues related to regulatory reform; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; Issues relating to FY27 appropriations; issues related to implementation of P.L. 119-21, One Big Beautiful Bill Act; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; S 717 Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; HR 6178 Increasing Access to Lung Cancer Screening Act; HR 6321 Lung Cancer Medicare Access to Precise Testing Act; HR 6320 Improving Medicaid Precision and Cancer Test Act of 2025; Consolidated Appropriations Act, 2026; HR 8839, Lanie Jones Comprehensive Cancer Survivorship Act of 2026; S. 4566, Increasing Access to Lung Cancer Screening Act; S. 5428, Stop the Wait Act of 2026","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"Issues related to tobacco use, lung cancer, lung disease treatment, prevention and research; and public health; Issues relating to the Presidents FY25 budget; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; Issues relating to FY27 appropriations; Issues related to the Congressional Directed Medical Research Program; HR 4016 Department of Defense Appropriations Act, 2026; S 2572 Department of Defense Appropriations Act, 2026; HR 9495, Department of Defense Appropriations Act, 2027","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TOB","general_issue_code_display":"Tobacco","description":"Issues related to lung disease treatment, prevention and research; Issues related to tobacco cessation; Issues related to agency restructuring; Issues related to smokefree air; Issues related to the Tobacco Control Act; Issues related to tobacco smuggling; Issues related to the Affordable Care Act; Issues related to menthol cigarettes; Issues related to tobacco prevention; Issues related to youth cessation research; Issues related to nicotine; Issues related to health equity; Issues related to COVID-19 Response; Issues related to tobacco litter; Issues related to synthetic nicotine; Issues related to regulatory reform; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; Issues relating to FY27 appropriations; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; S. 2171 A bill to amend title 38, united States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes; H.R. 4121 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026; S 2256 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026; HR 6844 The Tobacco Tracking, Reporting, and Accountability for Compliance in Enforcement Act; HR 6845 Strengthening Task Force Operations to Prevent Illicit Vaping Act; S 3569 Strengthening Task Force Operations to Prevent Illicit Vaping Act; HR 8646, Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027; S 4257, Resources to Prevent Youth Vaping Act; H.R. 10068, Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act; S. 5312, Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Issues related to taxes on tobacco products; Issues related to the Affordable Care Act; Issues related to COVID-19; Issues related to infrastructure; Issues relating to FY26 appropriations; Issues relating to FY27 appropriations; S 317 Charitable Act; HR 801 Charitable Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":150198,"prefix":"mrs","prefix_display":"MRS.","first_name":"ELIZABETH","nickname":null,"middle_name":"ANNE MUELLER","last_name":"SCOTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"Issues related to lung disease treatment, prevention and research; Issues related to burn pits; Issues related to tobacco cessation; Issues related to smokefree air; Issues related to COVID-19 Response; Issues relating to FY26 appropriations; Issues relating to FY27 appropriations; S. 2171 A bill to amend title 38, united States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/8aa76a1c-844e-4c06-ae85-982473e899d8/","filing_uuid":"8aa76a1c-844e-4c06-ae85-982473e899d8","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/8aa76a1c-844e-4c06-ae85-982473e899d8/print/","filing_document_content_type":"text/html","income":null,"expenses":"70000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Laura Katherine Bender","dt_posted":"2026-10-20T14:08:23-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"1331 Pennsylvania Ave NW","registrant_address_2":"Suite 1425 North","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":2811,"url":"https://lda.gov/api/v1/registrants/2811/","house_registrant_id":30549,"name":"AMERICAN LUNG ASSOCIATION","description":null,"address_1":"1331 Pennsylvania Ave NW","address_2":"Suite 1425 North","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"LAURA BENDER","contact_telephone":"+1 202-715-3457","dt_updated":"2026-07-20T09:13:00.293676-04:00"},"client":{"id":103597,"url":"https://lda.gov/api/v1/clients/103597/","client_id":12,"name":"AMERICAN LUNG ASSOCIATION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-02"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Issues related to lung disease treatment, prevention and research; public health; tobacco control and air pollution; Issues related to the Affordable Care Act; Issues related to COVID-19 Response; Issues related to infrastructure; Issues related to agency restructuring; Issues relating to FY26 appropriations; Issues relating to FY27 appropriations; S 317 Charitable Act; HR 801 Charitable Act; Consolidated Appropriations Act, 2026; Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026; Breaking the Gridlock Act; HR 9171, Department of Interior, Environment and Related Agencies Appropriations Act, 207; HR 9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; HR 8646, Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027; S 4257, Resources to Prevent Youth Vaping Act; HR 9495, Department of Defense Appropriations Act, 2027; HR 6500, Continuing Appropriations and Extensions Act, 2027","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150198,"prefix":"mrs","prefix_display":"MRS.","first_name":"ELIZABETH","nickname":null,"middle_name":"ANNE MUELLER","last_name":"SCOTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":49,"name":"Environmental Protection Agency (EPA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CAW","general_issue_code_display":"Clean Air and Water (quality)","description":"Issues related to the health impacts of air pollution and climate change; Issues related to air pollution from stationary and mobile sources; Issues related to the Clean Air Act; Issues related to California Clean Air Act waivers; Issues related to permitting and regulatory reforms; Issues related to infrastructure; Issues related to agency restructuring; Issues relating to FY26 appropriations; Issues relating to FY27 appropriations; Issues related to implementation of the Inflation Reduction Act; Issues related to appliance efficiency; issues related to prescribed burning; S1072 Stop California from Advancing Regulatory Burden Act; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; HR 471 Fix Our Forests; HJ Res 15/SJ Res 4 Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Energy relating to \"Energy Conservation Program: Energy Conservation Standards for Commercial Water Heating Equipment\"; HR 903/S 341 Smoke and Heat Ready Communities Act; HR 1449 Energy Resilient Communities Act; S 711 Transportation Freedom Act; HR 1651 To nullify the final rule issued by the Environmental Protection Agency relating to \"New Source Performance Standards for Greenhouse Gas Emissions From New, Modified, and Reconstructed Fossil Fuel-Fired Electric Generating Units; Emission Guidelines for Greenhouse Gas Emissions From Existing Fossil Fuel-Fired Electric Generating Units; and Repeal of the Affordable Clean Energy Rule\"; HR 1415/S 623 No Industrial Restrictions In Secret (No IRIS) Act; HR 2140 DERA Act 2025; S 1072 Stop CARB Act of 2025; HR 2165 Choice in Automobile Retail Sales (CARS) Act; HR 346 Preserving Choice in Vehicle Purchases Act; HR 2288 To nullify the final rule of the Environmental Protection Agency titled \"Reconsideration of the National Ambient Air Quality Standards for Particulate Matter\"; HR 3889/S 2015 National Prescribed Fire Act; H.Res. 585 Recognizing the threat of extreme weather to childrens health and wellbeing, and expressing the sense of Congress that solutions must be rapidly and equitably developed and deployed to address the unique vulnerabilities and needs of children; HR 4443/S 2298 Asuncion Valdivia Heat Illness, Injury, and Fatality Prevention Act; S 2340/HR 4515 Climate Change Health Protection and Promotion Act of 2025; HR 4744/S 2445 Community Mental Wellness and Resilience Act; HR 161 New Source Review Permitting Improvement Act; HR 6387 Fire Improvement and Reforming Exceptional Events Act; HR 6409 Foreign Emissions and Nonattainment Clarification for Economic Stability Act; HR 6398 Reducing and Eliminating Duplicative Environmental Regulations Act; HR 6373 Air Permitting Improvements to Protect National Security Act; H.R. 4214 Clean Air and Building Infrastructure Improvement Act; HR 4776 SPEED Act; S 3529 Public Health Air Quality Act; S 3007, Diesel Truck Liberation Act; S 237 Honoring Our Fallen Heroes Act; Commerce, Justice, Science; HR 5437 Protection of Lawful Commerce in Stone Slab Products Act; H.R. 4626 Home Appliance Protection and Affordability Act; H.R. 4758 Homeowner Energy Freedom Act; H.R. 7977 Energy Bills Relief Act; H.R. 7821 Promoting Reduction of Emissions through Landscaping Act; Discussion Draft of Legislation to Modernize the Toxic Substances Control Act ; H.R. 4593 SHOWER Act; H.R. 5184 Affordable HOMES Act; HR 4690, Reliable Federal Infrastructure Act; HR 3194, LOCOMOTIVES Act; HR 6200, ESSENTIAL Act; HR 6250, Cold Weather Diesel Reliability Act; HR 7000, Freedom to Fuel Act; HR 8782, PLOW Storms Act; HR 8870, Build America 250 Act; HR 9022, Fiscal Year 2027 Energy and Water Appropriations Bill; HR 9243/S 4732, Wildfire Smoke Emergency Declaration Act; HR 9453/S 4931, End EPA Abuse Act;HR 9171, Department of Interior, Environment and Related Agencies Appropriations Act, 2027; HR 9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; HR 9170, Transportation, Housing and Urban Development and Related Agencies Appropriations Act, 2027; HR 9317, Buses Utilizing Safety and Environmental Standards Act; HR 9618, Diesel Engine Flexibility Act; S 4404, No Passes for Polluters Act; S 5045, Wildfire Emissions Prevention Act; HR 9019, POWER Act; S 5092, Restoring Affordability in Automobile Manufacturing; S. 5311, Cabin Air Safety Act; S 5215, Cleaner Transportation Access for All; HR 10065, Methane Polluter Accountability Act; S5338, Energy Efficiency Reform Act; HR 10154, Protect America from CARB Act; HJ Res 202, Providing congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"California State Motor Vehicle Pollution Control Standards; Notice of Decision Granting a Waiver of Clean Air Act Preemption for California's 2009 and Subsequent Model Year Greenhouse Gas Emission Standards for New Motor Vehicles\"; HJ Res 211, Providing congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"California State Motor Vehicle Pollution Control Standards; Notice of Decision Granting a Waiver of Clean Air Act Preemption for California's 2009 and Subsequent Model Year Greenhouse Gas Emission Standards for New Motor Vehicles\"; SJ Res 206, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"California State Motor Vehicle Pollution Control Standards; Notice of Decision Granting a Waiver of Clean Air Act Preemption for California's 2009 and Subsequent Model Year Greenhouse Gas Emission Standards for New Motor Vehicles\"; SJ Res 207, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"California State Motor Vehicle Pollution Control Standards; Notice of Decision Granting a Waiver of Clean Air Act Preemption for California's Advanced Clean Car Program and a Within the Scope Conformation for California's Zero Emission Vehicle Amendments for 2017 and Earlier Model Years\"; HJ Res 212, Providing congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"California State Motor Vehicle Pollution Control Standards; Advanced Clean Car Program; Reconsideration of a Previous Withdrawal of a Waiver of Preemption; Notice of Decision\"; SJ Res 208, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"California State Motor Vehicle Pollution Control Standards; Advanced Clean Car Program; Reconsideration of a Previous Withdrawal of a Waiver of Preemption; Notice of Decision\"; HJ Res 214, Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"California State Nonroad Engine Pollution Control Standards; Small Off-Road Engines Regulations; Notice of Decision\"; SJ Res 205, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"California State Nonroad Engine Pollution Control Standards; Small Off-Road Engines Regulations; Notice of Decision; HJ Res 210, Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"California State Nonroad Engine Pollution Control Standards; Ocean-Going Vessels At-Berth; Notice of Decision\".; SJ Res 209, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"California State Nonroad Engine Pollution Control Standards; Ocean-Going Vessels At-Berth; Notice of Decision\"; HJ Res 213, Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule issued by the Environmental Protection Agency relating to the \"California State Nonroad Engine Pollution Control Standards; Commercial Harbor Craft Regulations; Notice of Decision\"; SJ Res 210, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating \"California State Nonroad Engine Pollution Control Standards; Commercial Harbor Craft Regulations; Notice of Decision\"; S. 5653, Bipartisan American Affordability and Jobs Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":150198,"prefix":"mrs","prefix_display":"MRS.","first_name":"ELIZABETH","nickname":null,"middle_name":"ANNE MUELLER","last_name":"SCOTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":33,"name":"Energy, Dept of"},{"id":49,"name":"Environmental Protection Agency (EPA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":36,"name":"Interior, Dept of (DOI)"},{"id":188,"name":"Internal Revenue Service (IRS)"},{"id":175,"name":"Natl Highway Traffic Safety Administration (NHTSA)"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"},{"id":40,"name":"Transportation, Dept of (DOT)"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to lung disease treatment, prevention and research; Issues related to public health; Issues related asthma, COPD, influenza, lung cancer, pneumonia, pulmonary fibrosis, tuberculosis and other lung diseases; Issues related to tobacco cessation; Issues related to the Affordable Care Act; Issues related to agency restructuring; Issues related to the Childrens Health Insurance Program; Issues related to Medicaid; Issues related to ERISA; Issues related to COVID-19 Response; Issues related to vaccines; Issues related to infrastructure; Issues related to supplemental oxygen; Issues related to the implementation of the No Surprises Act; Issues related to Medicare sequestration; Issues related to Cancer Moonshot; Issues related to short-term limited duration plans; Issues related to Healthy Future Taskforce; Issues related to regulatory reform; Issues relating to FY26 appropriations; Issues relating to FY27 appropriations; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 717Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; H.R. 3701 Family Vaccine Protection Act; H.R. 3521 Clinical Trial Modernization Act; HR 4417 Mobile Cancer Screening Act HR 3701 Family Vaccine Protection Act; HR 5304Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; S 2587 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; HR 5278/S 2756 Affordable Inhalers and Nebulizers Act of 2025; HR 6703 Lower Health Care Premiums for All Americans Act; S 2466 Senior Savings Protection Act; HR Senior Savings Protection Act; HR 6052 Elijah E. Cummings Family Asthma Act; HR 6319 Benay Taub Lung Cancer Research Act; HR 45448 Protecting Free Vaccines Act; Consolidated Appropriations Act, 2026; Breaking the Gridlock Act; HR 9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; S. 4440, Clinical Trial Modernization Act; S. 5428, Stop the Wait Act of 2026; H.R. 2319, Women and Lung Cancer Research and Preventive Services Act of 2025; S. 1157 Women and Lung Cancer Research and Preventive Services Act of 2025","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Issues relating to FY25 appropriations; Issues relating to the Presidents FY26 budget; Issues related to asthma, COPD, influenza, lung cancer, pneumonia, pulmonary fibrosis, tuberculosis and other lung diseases; Issues related to NIH reorganization; Issues related to agency restructuring; Issues related to lung disease treatment, prevention and research; Issues related to COVID-19; Issues related to telehealth; Issues related to infrastructure; Issues related to supplemental oxygen; Issues related to health equity; Issues related to Cancer Moonshot; Issues related to CDC public health workforce and data modernization; Issues related to regulatory reform; Issues related to Medicaid; H.R. 1509/S. 752, the Accelerating Kids Access to Care Act; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 717 Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; H.R. 3521 Clinical Trial Modernization Act; HR 4417 Mobile Cancer Screening Act; HR 5304 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; S 2587 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; HR 5278/S 2756 Affordable Inhalers and Nebulizers Act of 2025; HR 45448 Protecting Free Vaccines Act; HR 9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; S. 4440, Clinical Trial Modernization Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to lung disease treatment, prevention and research; Issues related to public health; Issues related to tobacco cessation; Issues related to health inequities; Issues related to Medicaid waivers; Issues related to agency restructuring; Issues related to the Affordable Care Act; Issues related to supplemental oxygen; Issues related to access to healthcare; Issues related to COVID-19 Response; Issues related to Medicaid; Issues related to infrastructure; Issues related to health equity; Issues related to the implementation of the No Surprises Act; Issues related to Medicaid; Issues relating to the Presidents FY25 budget; Issues related to regulatory reform; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; Issues relating to FY27 appropriations; issues related to implementation of P.L. 119-21, One Big Beautiful Bill Act; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; S 717 Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; HR 6178 Increasing Access to Lung Cancer Screening Act; HR 6321 Lung Cancer Medicare Access to Precise Testing Act; HR 6320 Improving Medicaid Precision and Cancer Test Act of 2025; Consolidated Appropriations Act, 2026; HR 8839, Lanie Jones Comprehensive Cancer Survivorship Act of 2026; S. 4566, Increasing Access to Lung Cancer Screening Act; S. 5428, Stop the Wait Act of 2026","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"Issues related to tobacco use, lung cancer, lung disease treatment, prevention and research; and public health; Issues relating to the Presidents FY25 budget; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; Issues relating to FY27 appropriations; Issues related to the Congressional Directed Medical Research Program; HR 4016 Department of Defense Appropriations Act, 2026; S 2572 Department of Defense Appropriations Act, 2026; HR 9495, Department of Defense Appropriations Act, 2027","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TOB","general_issue_code_display":"Tobacco","description":"Issues related to lung disease treatment, prevention and research; Issues related to tobacco cessation; Issues related to agency restructuring; Issues related to smokefree air; Issues related to the Tobacco Control Act; Issues related to tobacco smuggling; Issues related to the Affordable Care Act; Issues related to menthol cigarettes; Issues related to tobacco prevention; Issues related to youth cessation research; Issues related to nicotine; Issues related to health equity; Issues related to COVID-19 Response; Issues related to tobacco litter; Issues related to synthetic nicotine; Issues related to regulatory reform; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; Issues relating to FY27 appropriations; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; S. 2171 A bill to amend title 38, united States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes; H.R. 4121 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026; S 2256 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026; HR 6844 The Tobacco Tracking, Reporting, and Accountability for Compliance in Enforcement Act; HR 6845 Strengthening Task Force Operations to Prevent Illicit Vaping Act; S 3569 Strengthening Task Force Operations to Prevent Illicit Vaping Act; HR 8646, Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027; S 4257, Resources to Prevent Youth Vaping Act; H.R. 10068, Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act; S. 5312, Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Issues related to taxes on tobacco products; Issues related to the Affordable Care Act; Issues related to COVID-19; Issues related to infrastructure; Issues relating to FY26 appropriations; Issues relating to FY27 appropriations; S 317 Charitable Act; HR 801 Charitable Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":150198,"prefix":"mrs","prefix_display":"MRS.","first_name":"ELIZABETH","nickname":null,"middle_name":"ANNE MUELLER","last_name":"SCOTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"Issues related to lung disease treatment, prevention and research; Issues related to burn pits; Issues related to tobacco cessation; Issues related to smokefree air; Issues related to COVID-19 Response; Issues relating to FY26 appropriations; Issues relating to FY27 appropriations; S. 2171 A bill to amend title 38, united States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/8aa76a1c-844e-4c06-ae85-982473e899d8/","filing_uuid":"8aa76a1c-844e-4c06-ae85-982473e899d8","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/8aa76a1c-844e-4c06-ae85-982473e899d8/print/","filing_document_content_type":"text/html","income":null,"expenses":"70000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Laura Katherine Bender","dt_posted":"2026-10-20T14:08:23-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"1331 Pennsylvania Ave NW","registrant_address_2":"Suite 1425 North","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":2811,"url":"https://lda.gov/api/v1/registrants/2811/","house_registrant_id":30549,"name":"AMERICAN LUNG ASSOCIATION","description":null,"address_1":"1331 Pennsylvania Ave NW","address_2":"Suite 1425 North","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"LAURA BENDER","contact_telephone":"+1 202-715-3457","dt_updated":"2026-07-20T09:13:00.293676-04:00"},"client":{"id":103597,"url":"https://lda.gov/api/v1/clients/103597/","client_id":12,"name":"AMERICAN LUNG ASSOCIATION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-02"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Issues related to lung disease treatment, prevention and research; public health; tobacco control and air pollution; Issues related to the Affordable Care Act; Issues related to COVID-19 Response; Issues related to infrastructure; Issues related to agency restructuring; Issues relating to FY26 appropriations; Issues relating to FY27 appropriations; S 317 Charitable Act; HR 801 Charitable Act; Consolidated Appropriations Act, 2026; Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026; Breaking the Gridlock Act; HR 9171, Department of Interior, Environment and Related Agencies Appropriations Act, 207; HR 9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; HR 8646, Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027; S 4257, Resources to Prevent Youth Vaping Act; HR 9495, Department of Defense Appropriations Act, 2027; HR 6500, Continuing Appropriations and Extensions Act, 2027","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150198,"prefix":"mrs","prefix_display":"MRS.","first_name":"ELIZABETH","nickname":null,"middle_name":"ANNE MUELLER","last_name":"SCOTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":49,"name":"Environmental Protection Agency (EPA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CAW","general_issue_code_display":"Clean Air and Water (quality)","description":"Issues related to the health impacts of air pollution and climate change; Issues related to air pollution from stationary and mobile sources; Issues related to the Clean Air Act; Issues related to California Clean Air Act waivers; Issues related to permitting and regulatory reforms; Issues related to infrastructure; Issues related to agency restructuring; Issues relating to FY26 appropriations; Issues relating to FY27 appropriations; Issues related to implementation of the Inflation Reduction Act; Issues related to appliance efficiency; issues related to prescribed burning; S1072 Stop California from Advancing Regulatory Burden Act; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; HR 471 Fix Our Forests; HJ Res 15/SJ Res 4 Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Energy relating to \"Energy Conservation Program: Energy Conservation Standards for Commercial Water Heating Equipment\"; HR 903/S 341 Smoke and Heat Ready Communities Act; HR 1449 Energy Resilient Communities Act; S 711 Transportation Freedom Act; HR 1651 To nullify the final rule issued by the Environmental Protection Agency relating to \"New Source Performance Standards for Greenhouse Gas Emissions From New, Modified, and Reconstructed Fossil Fuel-Fired Electric Generating Units; Emission Guidelines for Greenhouse Gas Emissions From Existing Fossil Fuel-Fired Electric Generating Units; and Repeal of the Affordable Clean Energy Rule\"; HR 1415/S 623 No Industrial Restrictions In Secret (No IRIS) Act; HR 2140 DERA Act 2025; S 1072 Stop CARB Act of 2025; HR 2165 Choice in Automobile Retail Sales (CARS) Act; HR 346 Preserving Choice in Vehicle Purchases Act; HR 2288 To nullify the final rule of the Environmental Protection Agency titled \"Reconsideration of the National Ambient Air Quality Standards for Particulate Matter\"; HR 3889/S 2015 National Prescribed Fire Act; H.Res. 585 Recognizing the threat of extreme weather to childrens health and wellbeing, and expressing the sense of Congress that solutions must be rapidly and equitably developed and deployed to address the unique vulnerabilities and needs of children; HR 4443/S 2298 Asuncion Valdivia Heat Illness, Injury, and Fatality Prevention Act; S 2340/HR 4515 Climate Change Health Protection and Promotion Act of 2025; HR 4744/S 2445 Community Mental Wellness and Resilience Act; HR 161 New Source Review Permitting Improvement Act; HR 6387 Fire Improvement and Reforming Exceptional Events Act; HR 6409 Foreign Emissions and Nonattainment Clarification for Economic Stability Act; HR 6398 Reducing and Eliminating Duplicative Environmental Regulations Act; HR 6373 Air Permitting Improvements to Protect National Security Act; H.R. 4214 Clean Air and Building Infrastructure Improvement Act; HR 4776 SPEED Act; S 3529 Public Health Air Quality Act; S 3007, Diesel Truck Liberation Act; S 237 Honoring Our Fallen Heroes Act; Commerce, Justice, Science; HR 5437 Protection of Lawful Commerce in Stone Slab Products Act; H.R. 4626 Home Appliance Protection and Affordability Act; H.R. 4758 Homeowner Energy Freedom Act; H.R. 7977 Energy Bills Relief Act; H.R. 7821 Promoting Reduction of Emissions through Landscaping Act; Discussion Draft of Legislation to Modernize the Toxic Substances Control Act ; H.R. 4593 SHOWER Act; H.R. 5184 Affordable HOMES Act; HR 4690, Reliable Federal Infrastructure Act; HR 3194, LOCOMOTIVES Act; HR 6200, ESSENTIAL Act; HR 6250, Cold Weather Diesel Reliability Act; HR 7000, Freedom to Fuel Act; HR 8782, PLOW Storms Act; HR 8870, Build America 250 Act; HR 9022, Fiscal Year 2027 Energy and Water Appropriations Bill; HR 9243/S 4732, Wildfire Smoke Emergency Declaration Act; HR 9453/S 4931, End EPA Abuse Act;HR 9171, Department of Interior, Environment and Related Agencies Appropriations Act, 2027; HR 9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; HR 9170, Transportation, Housing and Urban Development and Related Agencies Appropriations Act, 2027; HR 9317, Buses Utilizing Safety and Environmental Standards Act; HR 9618, Diesel Engine Flexibility Act; S 4404, No Passes for Polluters Act; S 5045, Wildfire Emissions Prevention Act; HR 9019, POWER Act; S 5092, Restoring Affordability in Automobile Manufacturing; S. 5311, Cabin Air Safety Act; S 5215, Cleaner Transportation Access for All; HR 10065, Methane Polluter Accountability Act; S5338, Energy Efficiency Reform Act; HR 10154, Protect America from CARB Act; HJ Res 202, Providing congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"California State Motor Vehicle Pollution Control Standards; Notice of Decision Granting a Waiver of Clean Air Act Preemption for California's 2009 and Subsequent Model Year Greenhouse Gas Emission Standards for New Motor Vehicles\"; HJ Res 211, Providing congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"California State Motor Vehicle Pollution Control Standards; Notice of Decision Granting a Waiver of Clean Air Act Preemption for California's 2009 and Subsequent Model Year Greenhouse Gas Emission Standards for New Motor Vehicles\"; SJ Res 206, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"California State Motor Vehicle Pollution Control Standards; Notice of Decision Granting a Waiver of Clean Air Act Preemption for California's 2009 and Subsequent Model Year Greenhouse Gas Emission Standards for New Motor Vehicles\"; SJ Res 207, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"California State Motor Vehicle Pollution Control Standards; Notice of Decision Granting a Waiver of Clean Air Act Preemption for California's Advanced Clean Car Program and a Within the Scope Conformation for California's Zero Emission Vehicle Amendments for 2017 and Earlier Model Years\"; HJ Res 212, Providing congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"California State Motor Vehicle Pollution Control Standards; Advanced Clean Car Program; Reconsideration of a Previous Withdrawal of a Waiver of Preemption; Notice of Decision\"; SJ Res 208, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"California State Motor Vehicle Pollution Control Standards; Advanced Clean Car Program; Reconsideration of a Previous Withdrawal of a Waiver of Preemption; Notice of Decision\"; HJ Res 214, Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"California State Nonroad Engine Pollution Control Standards; Small Off-Road Engines Regulations; Notice of Decision\"; SJ Res 205, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"California State Nonroad Engine Pollution Control Standards; Small Off-Road Engines Regulations; Notice of Decision; HJ Res 210, Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"California State Nonroad Engine Pollution Control Standards; Ocean-Going Vessels At-Berth; Notice of Decision\".; SJ Res 209, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"California State Nonroad Engine Pollution Control Standards; Ocean-Going Vessels At-Berth; Notice of Decision\"; HJ Res 213, Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule issued by the Environmental Protection Agency relating to the \"California State Nonroad Engine Pollution Control Standards; Commercial Harbor Craft Regulations; Notice of Decision\"; SJ Res 210, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating \"California State Nonroad Engine Pollution Control Standards; Commercial Harbor Craft Regulations; Notice of Decision\"; S. 5653, Bipartisan American Affordability and Jobs Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":150198,"prefix":"mrs","prefix_display":"MRS.","first_name":"ELIZABETH","nickname":null,"middle_name":"ANNE MUELLER","last_name":"SCOTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":33,"name":"Energy, Dept of"},{"id":49,"name":"Environmental Protection Agency (EPA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":36,"name":"Interior, Dept of (DOI)"},{"id":188,"name":"Internal Revenue Service (IRS)"},{"id":175,"name":"Natl Highway Traffic Safety Administration (NHTSA)"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"},{"id":40,"name":"Transportation, Dept of (DOT)"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to lung disease treatment, prevention and research; Issues related to public health; Issues related asthma, COPD, influenza, lung cancer, pneumonia, pulmonary fibrosis, tuberculosis and other lung diseases; Issues related to tobacco cessation; Issues related to the Affordable Care Act; Issues related to agency restructuring; Issues related to the Childrens Health Insurance Program; Issues related to Medicaid; Issues related to ERISA; Issues related to COVID-19 Response; Issues related to vaccines; Issues related to infrastructure; Issues related to supplemental oxygen; Issues related to the implementation of the No Surprises Act; Issues related to Medicare sequestration; Issues related to Cancer Moonshot; Issues related to short-term limited duration plans; Issues related to Healthy Future Taskforce; Issues related to regulatory reform; Issues relating to FY26 appropriations; Issues relating to FY27 appropriations; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 717Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; H.R. 3701 Family Vaccine Protection Act; H.R. 3521 Clinical Trial Modernization Act; HR 4417 Mobile Cancer Screening Act HR 3701 Family Vaccine Protection Act; HR 5304Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; S 2587 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; HR 5278/S 2756 Affordable Inhalers and Nebulizers Act of 2025; HR 6703 Lower Health Care Premiums for All Americans Act; S 2466 Senior Savings Protection Act; HR Senior Savings Protection Act; HR 6052 Elijah E. Cummings Family Asthma Act; HR 6319 Benay Taub Lung Cancer Research Act; HR 45448 Protecting Free Vaccines Act; Consolidated Appropriations Act, 2026; Breaking the Gridlock Act; HR 9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; S. 4440, Clinical Trial Modernization Act; S. 5428, Stop the Wait Act of 2026; H.R. 2319, Women and Lung Cancer Research and Preventive Services Act of 2025; S. 1157 Women and Lung Cancer Research and Preventive Services Act of 2025","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Issues relating to FY25 appropriations; Issues relating to the Presidents FY26 budget; Issues related to asthma, COPD, influenza, lung cancer, pneumonia, pulmonary fibrosis, tuberculosis and other lung diseases; Issues related to NIH reorganization; Issues related to agency restructuring; Issues related to lung disease treatment, prevention and research; Issues related to COVID-19; Issues related to telehealth; Issues related to infrastructure; Issues related to supplemental oxygen; Issues related to health equity; Issues related to Cancer Moonshot; Issues related to CDC public health workforce and data modernization; Issues related to regulatory reform; Issues related to Medicaid; H.R. 1509/S. 752, the Accelerating Kids Access to Care Act; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 717 Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; H.R. 3521 Clinical Trial Modernization Act; HR 4417 Mobile Cancer Screening Act; HR 5304 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; S 2587 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; HR 5278/S 2756 Affordable Inhalers and Nebulizers Act of 2025; HR 45448 Protecting Free Vaccines Act; HR 9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; S. 4440, Clinical Trial Modernization Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to lung disease treatment, prevention and research; Issues related to public health; Issues related to tobacco cessation; Issues related to health inequities; Issues related to Medicaid waivers; Issues related to agency restructuring; Issues related to the Affordable Care Act; Issues related to supplemental oxygen; Issues related to access to healthcare; Issues related to COVID-19 Response; Issues related to Medicaid; Issues related to infrastructure; Issues related to health equity; Issues related to the implementation of the No Surprises Act; Issues related to Medicaid; Issues relating to the Presidents FY25 budget; Issues related to regulatory reform; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; Issues relating to FY27 appropriations; issues related to implementation of P.L. 119-21, One Big Beautiful Bill Act; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; S 717 Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; HR 6178 Increasing Access to Lung Cancer Screening Act; HR 6321 Lung Cancer Medicare Access to Precise Testing Act; HR 6320 Improving Medicaid Precision and Cancer Test Act of 2025; Consolidated Appropriations Act, 2026; HR 8839, Lanie Jones Comprehensive Cancer Survivorship Act of 2026; S. 4566, Increasing Access to Lung Cancer Screening Act; S. 5428, Stop the Wait Act of 2026","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"Issues related to tobacco use, lung cancer, lung disease treatment, prevention and research; and public health; Issues relating to the Presidents FY25 budget; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; Issues relating to FY27 appropriations; Issues related to the Congressional Directed Medical Research Program; HR 4016 Department of Defense Appropriations Act, 2026; S 2572 Department of Defense Appropriations Act, 2026; HR 9495, Department of Defense Appropriations Act, 2027","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TOB","general_issue_code_display":"Tobacco","description":"Issues related to lung disease treatment, prevention and research; Issues related to tobacco cessation; Issues related to agency restructuring; Issues related to smokefree air; Issues related to the Tobacco Control Act; Issues related to tobacco smuggling; Issues related to the Affordable Care Act; Issues related to menthol cigarettes; Issues related to tobacco prevention; Issues related to youth cessation research; Issues related to nicotine; Issues related to health equity; Issues related to COVID-19 Response; Issues related to tobacco litter; Issues related to synthetic nicotine; Issues related to regulatory reform; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; Issues relating to FY27 appropriations; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; S. 2171 A bill to amend title 38, united States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes; H.R. 4121 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026; S 2256 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026; HR 6844 The Tobacco Tracking, Reporting, and Accountability for Compliance in Enforcement Act; HR 6845 Strengthening Task Force Operations to Prevent Illicit Vaping Act; S 3569 Strengthening Task Force Operations to Prevent Illicit Vaping Act; HR 8646, Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027; S 4257, Resources to Prevent Youth Vaping Act; H.R. 10068, Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act; S. 5312, Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Issues related to taxes on tobacco products; Issues related to the Affordable Care Act; Issues related to COVID-19; Issues related to infrastructure; Issues relating to FY26 appropriations; Issues relating to FY27 appropriations; S 317 Charitable Act; HR 801 Charitable Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":150198,"prefix":"mrs","prefix_display":"MRS.","first_name":"ELIZABETH","nickname":null,"middle_name":"ANNE MUELLER","last_name":"SCOTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"Issues related to lung disease treatment, prevention and research; Issues related to burn pits; Issues related to tobacco cessation; Issues related to smokefree air; Issues related to COVID-19 Response; Issues relating to FY26 appropriations; Issues relating to FY27 appropriations; S. 2171 A bill to amend title 38, united States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/005d51ae-23e4-4e11-846f-70f56eb24c67/","filing_uuid":"005d51ae-23e4-4e11-846f-70f56eb24c67","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/005d51ae-23e4-4e11-846f-70f56eb24c67/print/","filing_document_content_type":"text/html","income":null,"expenses":"310000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Julie Stitzel","dt_posted":"2026-10-20T14:48:42-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"290 Harbor Drive","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Stamford","registrant_state":"CT","registrant_zip":"06902","registrant":{"id":401106760,"url":"https://lda.gov/api/v1/registrants/401106760/","house_registrant_id":45712,"name":"DIGITAL CURRENCY GROUP","description":null,"address_1":"262 Harbor Dr","address_2":null,"address_3":null,"address_4":null,"city":"Stamford","state":"CT","state_display":"Connecticut","zip":"06902","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JULIE STITZEL","contact_telephone":"+1 202-386-1259","dt_updated":"2026-07-20T14:39:02.223768-04:00"},"client":{"id":52614,"url":"https://lda.gov/api/v1/clients/52614/","client_id":52614,"name":"DIGITAL CURRENCY GROUP","general_description":"Support bitcoin & blockchain companies by leveraging insights, network & access to capital","client_government_entity":null,"client_self_select":true,"state":"CT","state_display":"Connecticut","country":"US","country_display":"United States of America","ppb_state":"CT","ppb_state_display":"Connecticut","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2022-07-01"},"lobbying_activities":[{"general_issue_code":"FIN","general_issue_code_display":"Financial Institutions/Investments/Securities","description":"General education around digital assets and decentralized AI To require the Secretary of the Treasury to develop a public-private partnership program with decentralized protocol developers and specialized auditing firms to examine embedded supervision and regulation of decentralized protocols, and for other purposes. H.R. 148, Keep Your Coins Act of 2025 S. 919, GENIUS Act H.R. 2392, STABLE Act H.R. 2384, Financial Technology Protection Act H.R.216, Securities Enforcement Clarity Act of 2025 H.R. 2365, Securities Clarity Act H.R.2032, BITCOIN Act H.Res.248, Resolution emphasizing the importance and power of distributed ledger technologies (DLT) to support democratic governance, human rights, internet freedom, and transparency. H.R. 1919, Anti-CBDC Surveillance State Act Legislation related to digital asset market structure legislation - HR 3633 (CLARITY Act) and the Responsible Financial Innovation Act of 2025. HR 1 (One Big Beautiful Bill Act) Issues related to the tax treatment of digital assets H.R.8149 - To amend the Internal Revenue Code of 1986 to clarify the tax treatment of digital asset rewards.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":139992,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"STITZEL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149565,"prefix":null,"prefix_display":null,"first_name":"TIFFANY","nickname":null,"middle_name":null,"last_name":"ANGULO","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"General education around digital assets and decentralized AI S.J. Res. 3, H.J. Res. 25 Resolution Disapproving Broker Rule Reconciliation/tax bill Legislation related to digital asset market structure legislation - HR 3633 (CLARITY Act) and the Responsible Financial Innovation Act of 2025. HR 1 (One Big Beautiful Bill Act) Issues related to the tax treatment of digital assets H.R.8149 - To amend the Internal Revenue Code of 1986 to clarify the tax treatment of digital asset rewards.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":139992,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"STITZEL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149565,"prefix":null,"prefix_display":null,"first_name":"TIFFANY","nickname":null,"middle_name":null,"last_name":"ANGULO","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"BAN","general_issue_code_display":"Banking","description":"General education around digital assets and decentralized AI S.875, FIRM Act S. 401, H.R. 987 Fair Access to Banking Act Legislation related to digital asset market structure legislation - HR 3633 (CLARITY Act) and the Responsible Financial Innovation Act of 2025. HR 1 (One Big Beautiful Bill Act) Issues related to the tax treatment of digital assets H.R.8149 - To amend the Internal Revenue Code of 1986 to clarify the tax treatment of digital asset rewards.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":139992,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"STITZEL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149565,"prefix":null,"prefix_display":null,"first_name":"TIFFANY","nickname":null,"middle_name":null,"last_name":"ANGULO","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"ENG","general_issue_code_display":"Energy/Nuclear","description":"General education around digital assets and decentralized AI Legislation related to digital asset market structure legislation - HR 3633 (CLARITY Act) and the Responsible Financial Innovation Act of 2025. HR 1 (One Big Beautiful Bill Act) Issues related to the tax treatment of digital assets H.R.8149 - To amend the Internal Revenue Code of 1986 to clarify the tax treatment of digital asset rewards.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":139992,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"STITZEL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149565,"prefix":null,"prefix_display":null,"first_name":"TIFFANY","nickname":null,"middle_name":null,"last_name":"ANGULO","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}]}